Departament Medicina Memòria 2006

1

Departament Medicina Memòria 2006

Docència, recerca i economia

2

Índex Docència Llicenciatura ...............................................................................................5 Doctorat.......................................................................................................7 Recerca Dermatologia...............................................................................................10 Malalties de la sang.....................................................................................12 Malalties de l'aparell càrdio-circulatori ......................................................14 Malalties de l'aparell digestiu ....................................................................16 Malalties de l'aparell respiratori..................................................................23 Malalties del sistema endocrí i de la nutrició..............................................32 Malalties del sistema excretor renal i genital masculí ................................35 Malalties del sistema nerviós ......................................................................36 Malalties infeccioses ..................................................................................40 Malalties reumatològiques i del sistema immune.......................................46 Medicina d'atenció primària........................................................................49 Oncologia clínica ........................................................................................53 Semiologia general i propedèutica..............................................................54 Hospitals col•laboradors .............................................................................56 Economia Funcionament ordinari ................................................................................61

3

Docència

4

5

Llicenciatura (Alumnes del curs 2006-2007) Assignatures troncals Crèdits Teoria Cr. Pràctiques Total Núm. Alumnes 3er. Curs Semiologia general i propedèutica....................................... 6 16 22 181 4rt. Curs Malalties de l'aparell càrdio-circulatori............................... 2,5 10,5 13 149 Malalties de l'aparell respiratori.......................................... 2,5 10,5 13 157 Malalties de la sang............................................................. 2,5 2 4,5 155 Oncologia clínica ................................................................ 2,5 2 4,5 156 Malalties de l'aparell digestiu ............................................. 2,5 10,5 13 152 Malalties del sistema nerviós............................................... 2,5 10,5 13 151 Malalties del sistema endocrí i de la nutrició...................... 4 3 7 158 5è. Curs Dermatologia...................................................................... 3 4 7 152 Medicina d'atenció primària............................................... 1 7 8 146 Malalties del sistema excretor renal i genital masculí........ 2,5 10,5 13 163 Malalties infeccioses ......................................................... 3,5 5 8,5 149 Malalties reumatològiques i del sistema immune ............. 2 3 5 140 Assignatures optatives Atenció multidisciplinària en el pacient vell .................... 4,5 4,5 60 Elements diagnòstics en medicina interna ....................... 4,5 4,5 49 Hematologia biològica. Diagnòstic de laboratori ............ 4,5 4,5 34 Indroducció al diagnòstic i tractament del malalt crític .. 6 6 48 Redacció mèdica ............................................................. 4,5 4,5 35 Síndrome d'immunodeficiència adquirida ...................... 4,5 4,5 35 Assignatures optatives com a treball pràctic Assistència clínica en zones urbanes socialment deprimides 15 15 6 Total................................................................................ 65,5 109,5 175 2.276

6

Hospitals i Centres de Salut i Atenció Primària associats al Departament de Medicina Hospital Clínic i Provincial de Barcelona Hospital Dos de Maig Hospital Esperit Sant Hospital General de Granollers Hospital General de l'Hospitalet Hospital Mútua de Terrassa CAPSE Rosselló EAP Casanovas CAPSE EAP Casc Antic EAP Dr Carles Ribas EAP El Clot EAP Gòtic EAP La Marina EAP La Mina EAP La Pau EAP Les Corts EAP Manso 2A Sant Antoni EAP Manso 2B Via Roma Manso EAP Poble Nou EAP Raval Nord Centre Dr. Lluis Sayé EAP Raval Sud

7

Doctorat Programa Biopatologia en Medicina: 2n any 36 alumnes Tesis aprovades: 17 Per publicacions 5 Format clàssic Total: 22 tesis aprovades Projectes de tesis d'alumnes amb suficiència investigadora inscrits pendents de presentar la tesi: Inscrits abans de 1998 Inscrits desprès de 1998 Total Alumnes de doctorat pla vell........ 63 25 88 Alumnes de doctorat pla 98.......... 28 28 Total...................... 116

8

9

Recerca

10

Dermatologia

Dermatologia - Publicacions 2006 Títol Autors Cita Original Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma.

Gallardo F; Bellosillo B; Espinet B; Pujol RM; Estrach T; Servitje O; Romagosa V; Barranco C; Boluda S; Garcia M; Sole F; Ariza A; Serrano S

Human pathology; 2006 Jul; 37(7); p. 867-73

Dermoscopy in epidermodysplasia verruciformis.

Segura S; Carrera C; Ferrando J; Mascaro JM Jr; Palou J; Malvehy J; Puig S

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al]; 2006 Jan; 32(1); p. 103-6

Diffuse and segmental variants of cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature

Badeloe S; van Geel M; van Steensel MA; Bastida J; Ferrando J; Steijlen PM; Frank J; Poblete-Gutierrez P

Experimental dermatology; 2006 Sep; 15(9); p. 735-41

EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome

Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S

European journal of cancer (Oxford, England : 1990); 2006 May; 42(8); p. 1014-30

Eosinophilic ulcer of the oral mucosa: another histological simulator of CD30+ lymphoproliferative disorders.

Segura S; Romero D; Mascaro JM Jr; Colomo L; Ferrando J; Estrach T

The British journal of dermatology; 2006 Aug; 155(2); p. 460-3

Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation

To-Figueras J; Badenas C; Carrera C; Munoz C; Mila M; Lecha M; Herrero C

Journal of inherited metabolic disease; 2006 Aug; 29(4); p. 580

Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation.

To-Figueras J; Badenas C; Carrera C; Munoz C; Mila M; Lecha M; Herrero C

Journal of inherited metabolic disease; 2006 Aug; 29(4); p. 580

Genetic studies in variegate porphyria in Spain. Identification of gene mutations and family study for carrier detection

Lecha M; Badenas C; Puig S; Orfila J; Mila M; To-Figueras J; Munoz C; Mercader P; Herrero C

Journal of the European Academy of Dermatology and Venereology : JEADV; 2006 Sep; 20(8); p. 974-9

Genetic studies in variegate porphyria in Spain. Identification of gene mutations and family study for carrier detection

Lecha M; Badenas C; Puig S; Orfila J; Mila M; To-Figueras J; Munoz C; Mercader P; Herrero C

ournal of the European Academy of Dermatology and Venereology : JEADV; 2006 Sep; 20(8); p. 974-9

Immunoadsorption against two distinct epitopes on human type XVII collagen abolishes dermal-epidermal separation induced in vitro by autoantibodies from pemphigoid gestationis patients

Herrero-Gonzalez JE; Brauns O; Egner R; Ronspeck W; Mascaro JM Jr; Jonkman MF; Zillikens D; Sitaru C

European journal of immunology; 2006 Apr; 36(4); p. 1039-48

11

National registry of Home Enteral Nutrition in 2003

Planas M; Lecha M; Garcia Luna PP; Pares RM; Chamorro J; Marti E; Bonada A; Irles JA; Boris MA; Cardona D; Zamarron I; Calanas AJ; Rodriguez A; Camarero E; Perez de la Cruz A; Mancha A; De Luis Roman D; Cos A; Luengo LM; Jimenez M; Bayo P; Goenaga MA

Nutricion hospitalaria : organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral; 2006 Jan-Feb; 21(1); p. 71-4

Results of radiotherapy in primary cutaneous lymphoma

Conill C; Navalpotro B; Lopez I; Estrach T Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico; 2006 Jun; 8(6); p. 430-4

The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection

Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG

Journal of the European Academy of Dermatology and Venereology : JEADV; 2006 Nov; 20(10); p. 1201-6

Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature.

Oranje AP; Devillers AC; Kunz B; Jones SL; DeRaeve L; Van Gysel D; de Waard-van der Spek FB; Grimalt R; Torrelo A; Stevens J; Harper J


Cas Clínic An embossed tattoo Munoz C; Guilabert A; Mascaro JM Jr; Lopez-Lerma

I; Vilaplana J Clinical and experimental dermatology; 2006 Mar; 31(2); p. 309-10

Atypical pemphigus: discordance between clinicopathological findings and the antigenic profile in four cases

Herrero-Gonzalez JE; Mascaro JM Jr; Iranzo P; Herrero C

Journal of cutaneous pathology; 2006 Jul; 33(7); p. 502-7

Carta Autoantibodies from patients with BSLE inducing recruitment of leukocytes to the dermoepidermal junction and subepidermal splits in cryosections of human skin.

Herrero-Gonzalez JE; Mascaro JM Jr; Herrero C; Dilling A; Zillikens D; Sitaru C

Archives of dermatology; 2006 Nov; 142(11); p. 1513

Compound blue naevus: a potential simulator of melanoma

Carrera C; Ferrer B; Mascaro JM Jr; Palou J The British journal of dermatology; 2006 Jul; 155(1); p. 207-8

Erythema multiforme presenting as cholestatic acute hepatitis caused by Epstein-Barr virus

Carrera C; Alsina M; de Pablo IM; Iranzo P; Herrero C


Haemochromatosis gene mutations and response to chloroquine in sporadic porphyria cutanea tarda.

Toll A; Celis R; Ozalla MD; Ercilla MG; Herrero C Acta dermato-venereologica; 2006; 86(3); p. 279-80

Not all images serve more than a thousand words

Moreno Romero JA; Guilabert Vidal A; Mascaro-Galy JM; Ferrando J

Medicina clinica; 2006 Oct 14; 127(14); p. 558

Where has all that hair gone? Cutrone M; Grimalt R Clinical and experimental dermatology; 2006 Jan; 31(1); p. 136-7

12

Malalties de la Sang

Malalties de la Sang - Publicacions 2006 Títol Autors Cita Original Anti-D alloimmunization after D-mismatchet allogeneic hematopoietic stem cell transplatation in patients with hematologic diseases

Cid J, Lozano M, Fernandez F, Carreras E, Pereira A, Mazzara R, Ordinas A

Transfusion 2006;46:169-69

Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin

Galan AM; van Heerde WL; Escolar G; Ordinas A; Sixma J; de Groot PG;

European journal of clinical investigation; 2006 Sep; 36(9); p. 633-9

Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions

Escolar G; Bozzo J; Maragall S Drugs of today (Barcelona, Spain : 1998); 2006 Apr; 42(4); p. 223-36

Assessment of platelet function in horses: ultrastructure, flow cytometry, and perfusion techniques

Segura D; Monreal L; Perez-Pujol S; Pino M; Ordinas A; Brugues R; White JG; Escolar G

Journal of veterinary internal medicine / American College of Veterinary Internal Medicine; 2006 May-Jun; 20(3); p. 581-8

Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients

Bussolari R; Candini O; Colomer D; Corradini F; Guerzoni C; Mariani SA; Cattelani S; Silvestri C; Pecorari L; Iacobucci I; Soverini S; Fasano T; Martinelli G; Cervantes F; Calabretta B

Leukemia research; 2007 Feb; 31(2); p. 163-7

Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasia

Cervantes F; Alvarez-Larran A; Hernandez-Boluda JC; Sureda A; Granell M; Vallansot R; Besses C; Montserrat E

British journal of haematology; 2006 Jul; 134(2); p. 184-6

Effects of etamsylate on equine platelets: In vitro and in vivo studies

Segura D; Monreal L; Perez-Pujol S; Alonso A; Diaz-Ricart M; Brugues R; Ordinas A; Escolar G

Veterinary journal (London, England : 1997); 2006 Aug 9;

Effects of polyethylene glycol and hydroxyethyl starch in University of Wisconsin preservation solution on human red blood cell aggregation and viscosity

Mosbah IB; Franco-Gou R; Abdennebi HB; Hernandez R; Escolar G; Saidane D; Rosello-Catafau J; Peralta C

Transplantation proceedings; 2006 Jun; 38(5); p. 1229-35

Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity

Hernandez MR; Tonda R; Pedreno J; Salas E; Arderiu G; Pino M; Serradell M; Escolar G

Journal of cardiovascular medicine (Hagerstown, Md); 2006 Dec; 7(12); p. 859-65

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Druker BJ; Guilhot F; O'Brien SG; Gathmann I; Kantarjian H; Gattermann N; Deininger MW; Silver RT; Goldman JM; Stone RM; Cervantes F; Hochhaus A; Powell BL; Gabrilove JL; Rousselot P; Reiffers J; Cornelissen JJ; Hughes T; Agis H; Fischer T; Verhoef G; Sh

The New England journal of medicine; 2006 Dec 7; 355(23); p. 2408

Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution

Cervantes F; Alvarez-Larran A; Arellano-Rodrigo E; Granell M; Domingo A; Montserrat E

Leukemia; 2006 Jan; 20(1); p. 55-60

Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version

Marin R; Goicoechea MA; Gorostidi M; Cases A; Diez J; Escolar G; Fernandez-Vega F; Palomar R; Rodrigo E; Martinez I; Segura J

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia; 2006; 26(1); p. 31-44

13

Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status

Arellano-Rodrigo E; Alvarez-Larran A; Reverter JC; Villamor N; Colomer D; Cervantes F

Haematologica; 2006 Feb; 91(2); p. 169-75

Rivaroxaban Escolar G, Villalta J, Casals F, Bozzo J, Serradell N, Bolós J

Drug Future 2006; 31(6):484-493

Serotonergic mechanisms: a potential link between affective disorders and cardiovascular risk.

Escolar G; Diaz-Ricart M; Gomez-Gil E; Serra M; Gasto C; Bozzo J; Galan AM

Timely topics in medicine Cardiovascular diseases; 2006 Feb 1; 10; p. E3

Serotoninergic mechanisms: a potential link between affective disorders and cardiovascular risk

G Escolar, M Díaz-Ricart, E Gómez-Gil, M Serra, C Gastó, J Bozzo, AM Galán

Timely Top Med Cardiovasc Dis : 10:E3; 2006

Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia

Costa D; Carrio A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camos M; Cervantes F; Campo E

Cancer genetics and cytogenetics; 2006 Apr 1; 166(1); p. 89-93

Revisió Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Baccarani M; Saglio G; Goldman J; Hochhaus A; Simonsson B; Appelbaum F; Apperley J; Cervantes F; Cortes J; Deininger M; Gratwohl A; Guilhot F; Horowitz M; Hughes T; Kantarjian H; Larson R; Niederwieser D; Silver R; Hehlmann R

Blood; 2006 Sep 15; 108(6); p. 1809-20

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)

Tefferi A; Barosi G; Mesa RA; Cervantes F; Deeg HJ; Reilly JT; Verstovsek S; Dupriez B; Silver RT; Odenike O; Cortes J; Wadleigh M; Solberg LA Jr; Camoriano JK; Gisslinger H; Noel P; Thiele J; Vardiman JW; Hoffman R; Cross NC; Gilliland DG; Kantarjian H

Blood; 2006 Sep 1; 108(5); p. 1497-503

Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options

Mesa RA; Barosi G; Cervantes F; Reilly JT; Tefferi A Best practice & research Clinical haematology; 2006; 19(3); p. 495-517

Malalties de la sang - Projectes finançats 2006

Investigador Principal Referència Ajut Entitat Nom Projecte Import Durada Cervantes F U-2006-

FS060038-O

FIS Estudio de la relación entre la presencia de polimorfismos genéticos en los genes MDR1, hOCT1 y AGP1 y la respuesta la tratamiento con imatinib en los pacientes con leucemia mieloide crónica

62.900

2006-2008

Escolar G PB-B1-10007 Ag. de Gestió d'Ajuts Universitaris i de Recerca

Cooperación del colágeno, factor tisular depositado y desencriptado en la formación y propagación del trombo bajo condiciones de flujo

63.800 2006-2008

Escolar G PTR1995-0890-OP

Ministerio Ciencia y Tecnología

Desarrollo y evaluación toxicológica de prototipos de sustitivos sintéticos para los concentrados de plaquetas

81.000 2003-2006

Escolar G SAF2003-05780 Ministerio de Ciencia y Tecnología

Cooperación del colágeno, factor tisular depositado y desencriptado en la formación y propagación del trombo bajo condiciones de flujo

133.100 2003-2006

Escolar G SAF2006-08003 Ministerio Educación y Ciencia

Factor tisular circulante y asociado a las plaquetas: papel en la formación de trombos oclusivos sobre lesiones arteriales, implicaciones fisiológicas, clínicas y terapéuticas

137.000 2006-2009

Ordinas A 2005RG009532 Ag. de Gestió d'Ajuts Universitaris i de Recerca

Grup de fisiopatologia, d'hemostàsia i trombosi 31.600 2005.2008

14

Malalties de l'Aparell Càrdio-circulatori

Malalties Aparell Càrdio-circulatori - Publicacions 2006 Títol Autors Cita Original A Practical Approach With Outcome for the Prognostic Assessment of Non-ST-Segment Elevation Chest Pain and Normal Troponin

Sanchis J; Bodi V; Nunez J; Bosch MJ; Bertomeu-Gonzalez V; Consuegra L; Santas E; Gomez C; Bosch X; Chorro FJ; Llacer A

The American journal of cardiology; 2007 Mar 15; 99(6); p. 797-801

Anodal capture in cardiac resynchronization therapy implications for device programming

Tamborero D; Mont L; Alanis R; Berruezo A; Tolosana JM; Sitges M; Vidal B; Brugada J

Pacing and clinical electrophysiology : PACE; 2006 Sep; 29(9); p. 940-5

Clinical and echocardiographic follow-up of patients with hypertrophic obstructive cardiomyopathy treated by percutaneous septal ablation

Delgado V; Sitges M; Andrea R; Rivera S; Masotti M; Francino A; Azqueta M; Pare C; Betriu A

Revista espanola de cardiologia; 2006 Nov; 59(11); p. 1123-30

Complications of Native andProsthetic Valve Infective Endocarditis: Update in 2006

Anguera I; Del Rio A; Moreno A; Pare C; Mestres CA; Miro JM

Current infectious disease reports; 2006 Jun; 8(4); p. 280-8

Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome

Cordeiro JM; Barajas-Martinez H; Hong K; Burashnikov E; Pfeiffer R; Orsino AM; Wu YS; Hu D; Brugada J; Brugada P; Antzelevitch C; Dumaine R; Brugada R

Circulation; 2006 Nov 7; 114(19); p. 2026-33

Electrocardiogram interpretation and class I blocker challenge in Brugada syndrome

Brugada R; Brugada P; Brugada J Journal of electrocardiology; 2006 Oct; 39(4 Suppl); p. S115-8

European Heart Rhythm Association Guidance Document on cardiac rhythm management product performance

Auricchio A; Gropp M; Ludgate S; Vardas P; Brugada J; Priori SG

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology; 2006 May; 8(5); p. 313-22

Familial pseudo-Wolff-Parkinson-White syndrome

Sternick EB; Oliva A; Magalhaes LP; Gerken LM; Hong K; Santana O; Brugada P; Brugada J; Brugada R

Journal of cardiovascular electrophysiology; 2006 Jul; 17(7); p. 724-32

Hemodialysis prospective multicentric quality study

Parra E; Ramos R; Betriu A; Paniagua J; Belart M; Martin F; Martinez T

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia; 2006; 26(6); p. 688-94

Hemodialysis prospective multicentric quality study

Parra E; Ramos R; Betriu A; Paniagua J; Belart M; Martin F; Martinez T

Nefrologia; 2006; 26(6); p. 688-94

Hemolysis in mechanical bileaflet prostheses: experience with the Bicarbon valve

Josa M; Castella M; Pare C; Bedini JL; Cartana R; Mestres CA; Pomar JL; Mulet J

The Annals of thoracic surgery; 2006 Apr; 81(4); p. 1291-6

Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial

Chacko M; Lincoff AM; Wolski KE; Cohen DJ; Bittl JA; Lansky AJ; Tsuchiya Y; Betriu A; Yen MH; Chew DP; Cho L; Topol EJ

American heart journal; 2006 May; 151(5); p. 1032.e1-7

15

Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial

Kaul P; Chang WC; Lincoff AM; Aylward P; Betriu A; Bode C; Califf RM; Ohman EM; Guetta V; Steg PG; Van de Werf F; Armstrong PW

European heart journal; 2006 May; 27(10); p. 1198-206

Performance assessment of an emergency department chest pain unit

Bragulat E; Lopez B; Miro O; Coll-Vinent B; Jimenez S; Aparicio MJ; Heras M; Bosch X; Valls V; Sanchez M

Revista espanola de cardiologia; 2007 Mar; 60(3); p. 276-84

Periannular complications in infective endocarditis involving native aortic valves

Anguera I; Miro JM; Evangelista A; Cabell CH; San Roman JA; Vilacosta I; Almirante B; Ripoll T; Farinas MC; Anguita M; Navas E; Gonzalez-Juanatey C; Garcia-Bolao I; Munoz P; de Alarcon A; Sarria C; Rufi G; Miralles F; Pare C; Fowler VG Jr; Mestres CA; de

The American journal of cardiology; 2006 Nov 1; 98(9); p. 1254-60

Periannular complications in infective endocarditis involving prosthetic aortic valves

Anguera I; Miro JM; San Roman JA; de Alarcon A; Anguita M; Almirante B; Evangelista A; Cabell CH; Vilacosta I; Ripoll T; Munoz P; Navas E; Gonzalez-Juanatey C; Sarria C; Garcia-Bolao I; Farinas MC; Rufi G; Miralles F; Pare C; Fowler VG Jr; Mestres CA; de

The American journal of cardiology; 2006 Nov 1; 98(9); p. 1261-8

Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain

Sanchis J; Bodi V; Nunez J; Bertomeu V; Consuegra L; Bosch MJ; Gomez C; Bosch X; Chorro FJ; Llacer A

The American journal of cardiology; 2006 Oct 1; 98(7); p. 885-9

Recurrent syncope: an unusual presentation of Brugada syndrome

Benito B; Brugada J Nature clinical practice Cardiovascular medicine; 2006 Oct; 3(10); p. 573-7; quiz following 577

Relation of response to cardiac resynchronization therapy to left ventricular reverse remodeling

Vidal B; Sitges M; Marigliano A; Diaz-Infante E; Azqueta M; Tamborero D; Macias A; Roig E; Brugada J; Pare C; Mont L

The American journal of cardiology; 2006 Mar 15; 97(6); p. 876-81

Specialized care program for end-stage heart failure patients. Initial experience in a heart failure unit

Roig E; Perez-Villa F; Cuppoletti A; Castillo M; Hernandez N; Morales M; Betriu A

Revista espanola de cardiologia; 2006 Feb; 59(2); p. 109-16

Sport practice and the risk of lone atrial fibrillation: a case-control study

Elosua R; Arquer A; Mont L; Sambola A; Molina L; Garcia-Moran E; Brugada J; Marrugat J

International journal of cardiology; 2006 Apr 14; 108(3); p. 332-7

Transient endothelial dysfunction is present shortly after cardioversion in patients with lone atrial fibrillation

Coll-Vinent B; Monteagudo J; Miro O; Luis Marin J; Nava S; Scalise A; Sanchez M; Bragulat E; Sitges M; Brugada J; Mont L

Thrombosis research; 2006; 117(3); p. 235-40

Cas Clínic Epicardial ablation of syncopal ventricular tachycardia. Utility of the electrocardiogram

Berruezo A; Cano L; Mont L; Brugada J Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology; 2006 May; 8(5); p. 338-40

Images in cardiology. Left ventricular pseudoaneurysm complicating acute myocardial infarction: improved diagnosis by real time three dimensional echocardiography

Freixa X; Sitges M; Pare C Heart (British Cardiac Society); 2006 Feb; 92(2); p. 154

16

Malalties de l'Aparell Digestiu

Malalties de l'Aparell Digestiu - Publicacions 2006 Títol Autors Cita Originals A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis

Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL

Gastroenterology; 2006 Dec; 131(6); p. 1758-67

Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease

Garcia Rodriguez LA; Ruigomez A; Panes J Gastroenterology; 2006 May; 130(6); p. 1588-94

Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.

Fernandez J; Escorsell A; Zabalza M; Felipe V; Navasa M; Mas A; Lacy AM; Gines P; Arroyo V

Hepatology (Baltimore, Md); 2006 Nov; 44(5); p. 1288-95

Anti-inflammatory effects of low-dose radiotherapy in an experimental model of systemic inflammation in mice

Arenas M; Gil F; Gironella M; Hernandez V; Jorcano S; Biete A; Pique JM; Panes J

International journal of radiation oncology, biology, physics; 2006 Oct 1; 66(2); p. 560-7

Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice

Justicia C; Martin A; Rojas S; Gironella M; Cervera A; Panes J; Chamorro A; Planas AM

ournal of cerebral blood flow and metabolism; 2006 Mar; 26(3); p. 421-32

Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome

Esteva-Font C; Baccaro ME; Fernandez-Llama P; Sans L; Guevara M; Ars E; Jimenez W; Arroyo V; Ballarin JA; Gines P

Hepatology (Baltimore, Md); 2006 Dec; 44(6); p. 1555-63

Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension

Hernandez-Guerra M; Garcia-Pagan JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J

Hepatology (Baltimore, Md); 2006 Mar; 43(3); p. 485-91

Caroli's disease Bruguera M; Ros E Gastroenterologia y hepatologia; 2006 Oct; 29(8); p. 462-7

Cation-pi Interactions and oxidative effects on Cu+ and Cu2+ binding to Phe, Tyr, Trp, and His amino acids in the gas phase. Insights from first-principles calculations

Rimola A; Rodriguez-Santiago L; Sodupe M The journal of physical chemistry B, Condensed matter, materials, surfaces, interfaces & biophysical; 2006 Nov 30; 110(47); p. 24189-99

Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjogren's syndrome

Ramos-Casals M; Sanchez-Tapias JM; Pares A; Forns X; Brito-Zeron P; Nardi N; Vazquez P; Velez D; Arias I; Bove A; Plaza J; Rodes J; Font J

The Journal of rheumatology; 2006 Aug; 33(8); p. 1593-9

Clinical practice guideline for irritable bowel syndrome

Tort S; Balboa A; Marzo M; Carrillo R; Minguez M; Valdeperez J; Alonso-Coello P; Mascort JJ; Ferrandiz J; Bonfill X; Pique JM; Mearin F

Gastroenterologia y hepatologia; 2006 Oct; 29(8); p. 467-521

Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease

Cabriada JL; Domenech E; Gomollon F; Gonzalez-Carro P; Gonzalez-Lara V; Hinojosa J; Jimenez-Lopez CE; Nos P; Obrador A; Panes J; Saro C; Varea V; Lafuente R; Guilera M

Gastroenterologia y hepatologia; 2006 Feb; 29(2); p. 85-92

Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency

Castells A; Paya A; Alenda C; Rodriguez-Moranta F; Agrelo R; Andreu M; Pinol V; Castellvi-Bel S; Jover R; Llor X; Pons E; Elizalde JI; Bessa X; Alcedo J; Salo J; Medina E; Naranjo A; Esteller M; Pique JM

Clinical cancer research : an official journal of the American Association for Cancer Research; 2006 Mar 15; 12(6); p. 1686-92

17

Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts

Figueras J; Prieto M; Bernardos A; Rimola A; Suarez F; de Urbina JO; Cuervas-Mons V; Mata Mde L

Transplant international : official journal of the European Society for Organ Transplantation; 2006 Aug; 19(8); p. 641-8

Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis

Lederer SL; Walters KA; Proll S; Paeper B; Robinzon S; Boix L; Fausto N; Bruix J; Katze MG

Virology journal; 2006 Nov 22; 3; p. 98

Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA

Gonzalez-Periz A; Planaguma A; Gronert K; Miquel R; Lopez-Parra M; Titos E; Horrillo R; Ferre N; Deulofeu R; Arroyo V; Rodes J; Claria J

The FASEB journal; 2006 Dec; 20(14); p. 2537-9

Does silica surface catalyse peptide bond formation? New insights from first-principles calculations

Rimola A; Tosoni S; Sodupe M; Ugliengo P Chemphyschem : a European journal of chemical physics and physical chemistry; 2006 Jan 16; 7(1); p. 157-63

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation

Kremer-Tal S; Narla G; Chen Y; Hod E; Difeo A; Yea S; Lee JS; Schwartz M; Thung SN; Fiel IM; Banck M; Zimran E; Thorgeirsson SS; Mazzaferro V; Bruix J; Martignetti JA; Llovet JM; Friedman SL

Journal of hepatology; 2006 Nov 27

Effects of propranolol on venous compliance in conscious rats with pre-hepatic portal hypertension

Andreu V; Garcia-Pagan JC; Lionetti R; Piera C; Abraldes JG; Bosch J

Journal of hepatology; 2006 Jun; 44(6); p. 1040-5

Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension

Luca A; Miraglia R; Caruso S; Milazzo M; Gidelli B; Bosch J

Liver transplantation; 2006 Aug; 12(8); p. 1237-43

Endoscopic ultrasonography in patients with large gastric folds at endoscopy and biopsies negative for malignancy: predictors of malignant disease and clinical impact

Gines A; Pellise M; Fernandez-Esparrach G; Soria MT; Mata A; Membrillo A; Martinez-Palli G; Sole MM; Llach J; Bordas JM; Pique JM

The American journal of gastroenterology; 2006 Jan; 101(1); p. 64-9

Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid

Pares A; Caballeria L; Rodes J Gastroenterology; 2006 Mar; 130(3); p. 715-20

Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there

Llovet JM; Schwartz M; Fuster J; Bruix J Seminars in liver disease; 2006 Aug; 26(3); p. 248-53

Gene expression profiling of renal dysfunction in rats with experimental cirrhosis

Lopez-Parra M; Telleria N; Titos E; Planaguma A; Gonzalez-Periz A; Arroyo V; Rodes J; Claria J

Journal of hepatology; 2006 Aug; 45(2); p. 221-9

Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats

Angermayr B; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J; Fernandez M

Journal of hepatology; 2006 Jun; 44(6); p. 1033-9

Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: A systematic review

D'Amico G; Garcia-Pagan JC, Luca A; Bosch J Gastroenterology; 2006;131:1611-24

Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation

Blasco A; Forns X; Carrion JA; Garcia-Pagan JC; Gilabert R; Rimola A; Miquel R; Bruguera M; Garcia-Valdecasas JC; Bosch J; Navasa M

Hepatology (Baltimore, Md); 2006 Mar; 43(3); p. 492-9

18

Hepatitis B vaccine and multiple sclerosis: an unproved association

Salleras L; Bruguera M; Prat A Medicina clinica; 2006 Apr 22; 126(15); p. 581-8

Hepatocarcinoma and HCV Forner A; Varela M; Bruix J Gastroenterologia y hepatologia; 2006 Oct; 29 Suppl 2; p. 196-9

Hepatocellular carcinoma in the setting of liver transplantation

Varela M; Sanchez W; Bruix J; Gores GJ Liver transplantation; 2006 Jul; 12(7); p. 1028-36

How ischaemic preconditioning protects small liver grafts

Franco-Gou R; Rosello-Catafau J; Casillas-Ramirez A; Massip-Salcedo M; Rimola A; Calvo N; Bartrons R; Peralta C

The Journal of pathology; 2006 Jan; 208(1); p. 62-73

Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation

Londono MC; Guevara M; Rimola A; Navasa M; Taura P; Mas A; Garcia-Valdecasas JC; Arroyo V; Gines P

Gastroenterology; 2006 Apr; 130(4); p. 1135-43

Hyponatremia in cirrhosis: clinical features and management

Martin-Llahi M; Guevara M; Gines P Gastroenterologie clinique et biologique; 2006 Oct; 30(10); p. 1144-51

Hyponatremia in cirrhosis: Results of a patient population survey

Angeli P; Wong F; Watson H; Gines P Hepatology (Baltimore, Md); 2006 Dec; 44(6); p. 1535-42

Impact of upper digestive symptoms in patients with irritable bowel syndrome

Balboa A; Mearin F; Badia X; Benavent J; Caballero AM; Dominguez-Munoz JE; Garrigues V; Pique JM; Roset M; Cucala M; Figueras M

European journal of gastroenterology & hepatology; 2006 Dec; 18(12); p. 1271-7

Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats

Fernandez-Varo G; Morales-Ruiz M; Ros J; Tugues S; Munoz-Luque J; Casals G; Arroyo V; Rodes J; Jimenez W;

Journal of hepatology; 2007 Mar; 46(3); p. 440-446

Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis

Turnes J; Hernandez-Guerra M; Abraldes JG; Bellot P; Oliva R; Garcia-Pagan JC; Bosch J

Hepatology (Baltimore, Md); 2006 Jan; 43(1); p. 34-41

Interaction of glycine with isolated hydroxyl groups at the silica surface: first principles B3LYP periodic simulation

Rimola A; Sodupe M; Tosoni S; Civalleri B; Ugliengo P

Langmuir : the ACS journal of surfaces and colloids; 2006 Jul 18; 22(15); p. 6593-604

Irritable intestine syndrome: a disease with a high social, economic, and health-service load

Pique JM; Lanas A Atencion primaria / Sociedad Espanola de Medicina de Familia y Comunitaria; 2006 Jun 30; 38(2); p. 69-71

Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?

Vilana R; Bianchi L; Varela M; Nicolau C; Sanchez M; Ayuso C; Garcia M; Sala M; Llovet JM; Bruix J; Bru C

European radiology; 2006 Nov; 16(11); p. 2454-62

Ischemia-reperfusion syndrome associated with liver transplantation: an update

Casillas-Ramirez A; Mosbah IB; Franco-Gou R; Rimola A; Rosello-Catafau J; Peralta C

Gastroenterologia y hepatologia; 2006 May; 29(5); p. 306-13

Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis

Angulo S; Llopis M; Antolin M; Gironella M; Sans M; Malagelada JR; Pique JM; Guarner F; Panes J

American journal of physiology Gastrointestinal and liver physiology; 2006 Dec; 291(6); p. G1155-62

Life events and inflammatory bowel disease relapse: a prospective study of patients enrolled in remission

Vidal A; Gomez-Gil E; Sans M; Portella MJ; Salamero M; Pique JM; Panes J

The American journal of gastroenterology; 2006 Apr; 101(4); p. 775-81

Management of ascites and hepatic hydrothorax

Cardenas A; Arroyo V Best practice & research Clinical gastroenterology; 2007; 21(1); p. 55-75

19

Management of gut ischemia Pique JM ndian journal of gastroenterology; 2006 Nov; 25 Suppl; p. S39-42

Microbiologic features and outcome of pneumonia in transplanted patients

Cervera C; Agusti C; Angeles Marcos M; Pumarola T; Cofan F; Navasa M; Perez-Villa F; Torres A; Moreno A

Diagnostic microbiology and infectious disease; 2006 May; 55(1); p. 47-54

Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy

Minguez B; Garcia-Pagan JC; Bosch J; Turnes J; Alonso J; Rovira A; Cordoba J

Hepatology (Baltimore, Md); 2006 Apr; 43(4); p. 707-14

Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells

Sancho-Bru P; Bataller R; Colmenero J; Gasull X; Moreno M; Arroyo V; Brenner DA; Gines P

American journal of physiology Gastrointestinal and liver physiology; 2006 Nov; 291(5); p. G877-84

Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage

Fernandez J; Ruiz del Arbol L; Gomez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M

Gastroenterology; 2006 Oct; 131(4); p. 1049-56; quiz 1285

Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis

Turnes J; Garcia-Pagan JC; Abraldes JG; Hernandez-Guerra M; Dell'Era A; Bosch J

The American journal of gastroenterology; 2006 Mar; 101(3); p. 506-12

Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial

Rodriguez-Moranta F; Salo J; Arcusa A; Boadas J; Pinol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Pique JM; Castells A

Journal of clinical oncology; 2006 Jan 20; 24(3); p. 386-93

Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients

Mearin F; Badia X; Balboa A; Benavent J; Caballero AM; Dominguez-Munoz E; Garrigues V; Pique JM; Roset M; Cucala M; Figueras M

Alimentary pharmacology & therapeutics; 2006 Mar 15; 23(6); p. 815-26

Prevalence of gastro-oesophageal reflux disease in Spain and associated factors

Ponce J; Vegazo O; Beltran B; Jimenez J; Zapardiel J; Calle D; Pique JM

Alimentary pharmacology & therapeutics; 2006 Jan 1; 23(1); p. 175-84

Prevention of viral hepatitis Bruguera M Enfermedades infecciosas y microbiologia clinica; 2006 Dec; 24(10); p. 649-56

Prospective assessment of the role of antibiotic prophylaxis in ERCP

Llach J; Bordas JM; Almela M; Pellise M; Mata A; Soria M; Fernandez-Esparrach G; Gines A; Elizalde JI; Feu F; Pique JM

Hepato-gastroenterology; 2006 Jul-Aug; 53(70); p. 540-2

Purification of recombinant histidine-tag streptolysin O using immobilized metal affinity expanded bed adsorption (IMA-EBA)

Camprubi S; Bruguera M; Canalias F International journal of biological macromolecules; 2006 Mar 30; 38(2); p. 134-9

Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells

Bertolani C; Sancho-Bru P; Failli P; Bataller R; Aleffi S; DeFranco R; Mazzinghi B; Romagnani P; Milani S; Gines P; Colmenero J; Parola M; Gelmini S; Tarquini R; Laffi G; Pinzani M; Marra F

The American journal of pathology; 2006 Dec; 169(6); p. 2042-53

Risk assessment in relatives of gastric cancer patients: hyperproliferation, genetics, and Helicobacter pylori infection

Ignasi Elizalde J; Pique JM European journal of gastroenterology & hepatology; 2006 Aug; 18(8); p. 877-9

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

Lanas A; Garcia-Rodriguez LA; Arroyo MT; Gomollon F; Feu F; Gonzalez-Perez A; Zapata E; Bastida G; Rodrigo L; Santolaria S; Guell M; de Argila CM; Quintero E; Borda F; Pique JM

Gut; 2006 Dec; 55(12); p. 1731-8

20

Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil

Brunet M; Cirera I; Martorell J; Vidal E; Millan O; Jimenez O; Rojo I; Londono MC; Rimola A

Transplantation; 2006 Feb 27; 81(4); p. 541-6

Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation

Martinez-Palli G; Gomez FP; Barbera JA; Navasa M; Roca J; Rodriguez-Roisin R; Burgos F; Gistau C

World journal of gastroenterology : WJG; 2006 Sep 28; 12(36); p. 5878-83

Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome

Hernandez-Guerra M; Lopez E; Bellot P; Piera C; Turnes J; Abraldes JG; Bosch J; Garcia-Pagan JC

Hepatology (Baltimore, Md); 2006 Jan; 43(1); p. 27-33

The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis

Matei V; Rodriguez-Vilarrupla A; Deulofeu R; Colomer D; Fernandez M; Bosch J; Garcia-Pagan JC

Hepatology (Baltimore, Md); 2006 Jul; 44(1); p. 44-52

The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection

Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG


TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease

Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Pique JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C

Journal of immunology (Baltimore, Md : 1950); 2006 Feb 15; 176(4); p. 2617-24

Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation

Carrion JA; Navasa M; Bosch J; Bruguera M; Gilabert R; Forns X

Liver transplantation; 2006 Dec; 12(12); p. 1791-8

Wilson's disease Bruguera M Gastroenterologia y hepatologia; 2006 Jan; 29(1); p. 29-33

Revisió Cavernous hemangioma Bruguera M Gastroenterologia y hepatologia; 2006

Aug-Sep; 29(7); p. 428-30 Hepatitis C in Spain Bruguera M; Forns X Medicina clinica; 2006 Jun 17; 127(3);

p. 113-7 Hepatorenal syndrome Cardenas A; Gines P Clinics in liver disease; 2006 May;

10(2); p. 371-85, ix-x Hyponatremia in cirrhosis: clinical features and management

Martin-Llahi; Guevara M, GInez P Gastroenterol Clin Biol 2006;30:1144-51

Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?

Miro JM; Laguno M; Moreno A; Rimola A Journal of hepatology; 2006; 44(1 Suppl); p. S140-5

Measurement of portal pressure and its role in the management of chronic liver disease

Bosch J; Garcia-Pagan JC; Berzigotti A; Abraldes JG

Seminars in liver disease; 2006 Nov; 26(4); p. 348-62

New aspects of diagnosis and therapy of hepatocellular carcinoma

Bruix J; Hessheimer AJ; Forner A; Boix L; Vilana R; Llovet JM

Oncogene; 2006 Jun 26; 25(27); p. 3848-56

New treatments of hepatorenal syndrome

Arroyo V; Terra C; Gines P Seminars in liver disease; 2006 Aug; 26(3); p. 254-64

Predictions from a hard liver Bosch J Journal of hepatology; 2006 Aug; 45(2); p. 230-5

21

Therapy insight: Management of hepatorenal syndrome

Cardenas A; Gines P Nature clinical practice Gastroenterology & hepatology; 2006 Jun; 3(6); p. 338-48

Treatment of hepatocellular carcinoma

Forner A; Hessheimer AJ; Isabel Real M; Bruix J Critical reviews in oncology/hematology; 2006 Nov; 60(2); p. 89-98

Cas Clínic Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome

Mundo J; Peris P; Monegal A; Navasa M; Cervera R; Guaniabens N

Lupus; 2006; 15(5); p. 304-7

Editorial A brief dictionary of eponyms used in gastroenterology

Bruguera M Gastroenterologia y hepatologia; 2006 Mar; 29(3); p. 125-30

Diagnosis and staging of hepatocellular carcinoma prior to transplantation: expertise or failure

Varela M; Forner A; Bruix J Liver transplantation; 2006 Oct; 12(10); p. 1445-7

Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients

Varela M; Bruix J Journal of hepatology; 2006 Jan; 44(1); p. 8-10

Presentation Arroyo V Gastroenterologia y hepatologia; 2006 Oct; 29 Suppl 2; p. 1

Unmet needs in the approach to irritable bowel syndrome

Pique JM; Lanas A Gastroenterologia y hepatologia; 2006 Jun-Jul; 29(6); p. 349-51

Carta Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route

Conget I; Piquer S; Julia M; Gomis R; Esmatjes E; Garcia-Pagan JC; Bosch J; Gilabert R; Ricart MJ; Fernandez-Cruz L; Manyalich M

Transplantation; 2006 Apr 27; 81(8); p. 1220-1

Is oral ciclosporin necessary to switch from i.v. to thiopurines?

Domenech E; Gomollon F; Obrador A; Panes J; Gassull MA

Alimentary pharmacology & therapeutics; 2006 Feb 15; 23(4); 555-6; author reply 556-7

Transmission of HIV-1 from an obstetrician to a patient during a caesarean section

Mallolas J; Gatell JM; Bruguera M AIDS (London, England); 2006 Aug 22; 20(13); p. 1785

Capítul llibre Ascites and spontaneous bacterial peritonitis

Cárdenas A, Ginès P, Rodés J En: Therapy of Digestive Disorders 2nd Ed. Wolfe MM, Davis GL, Farraye F, Giannella RA, Malagelada JR, Steer ML. Eds. Saunders 2006, 607-18

Complications of Cirrhosis: Ascites, Hyponatremia, Hepatorenal Syndrome, and Spontaneous Bacterial Peritonitis

Cárdenas A, Ginès P, Arroyo V, Rodés J In: Comprehensive Clinical Hepatology, 2nd Ed. O’Grady J and Bacon B Eds. Mosby. 2006, 153-168.

Hemorragia digestiva por hipertensión portal

García-Pagán JC, Bosch J. En: Problemas comunes en la práctica clínica. Gastroenterología y Hepatología. Tomo II (MA. Montoro)Jarpyo Editoreas SA Madrid 2006- ISBN (2 tomos):84-96549-26-7.

Hepatocellular Carcinoma J. Maurel , J. Bruix En : Hematology-Oncology Therapy. Editor: Michael M. Boyiadzis, Peter F. Lebowitz, James N. Frame, Tito Fojo.2006: 179-182.

22

Hepatocellular Carcinoma J. Bruix, C. Brú, JM. Llovet En: Hepatology, a textbook of liver disease. Editor: Tomas D. Boyer, Teresa L. Wright, Michael P. Manns. Zakim and Boyer’s 2006. 1109 – 1131

Hepatoma M. Varela, M. Sala, J. Bruix En: Medical care of the Liver Transplant Patient. Editor: Paul G. Killenberg & Pierre-Alain Clavien, 2006: 119-138

Hepatorenal Syndrome Arroyo V, Ginès P, Terra C, Torre A En: Clinical critical care medicine. Eds: Albert RK, Slutsky A, Ranieri M, Takala J, Torres A. Mosby Elsevier. 489-96

Hepatorenal syndrome: current concepts

Cardenas A, Ginès P Eds de Franchis R. Portal Hypertension IV- Procc. Of the Fourth Baveno 2005. Blackwell. Oxford, 2006, 201-16.

Hyponatremia: a risk factor of hepatic encephalopathy in cirrosis

Guevara M, Ginès P EN: Hepatic encephalopathy and nitrogen metabolism. Eds. Häussinger D, Kirscheis G, Schlies F. Springer 2006, 458-66.

Prólogo J. Bruix En: Pathology of Hepatocellular Carcinoma: Editor: Masamichi Kokjiro. 2006

Renal Dysfunction in Cirrhosis: Pathophysiology on Clinical Features

Arroyo V, Ginès P, Guevara M, Rodés J En: Zakim D, Boyer J (eds) 5th Edition. Hepatology. A text book of liver diseases. 2006, 417-52.

Treatment of the acute bleeding episode

Laine L, Planas R, Nevens F, Bañares R, Patch D, Bosch J

En: Portal Hypertension IV. Procedings of the Fourth Baveno International COnsensus Workshop. Ed: Roberto de Franchis. Ed: Blackwell Publishing Ltd. Oxford, 2006. ISBN-13: 978-1-4051-3940-3. IBC-10:1-4051-3940-4

Malalties de l'Aparell Digestiu - Projectes Finançats 2006 Inv. Principal Ref. Ajut Entitat Nom Projecte Import € Durada Arroyo V 00071 Agència de Gestió

d’Ajuts Universitaris i de Recerca (AGAUR) - SGR

Grup de Recerca en Hepatología Clínica 50.600 ???

Bosch J

PI 04/0655

Fondo Investigacion Sanitaria

Hemodinámica hepática e hipertensión portal. Nuevos desarrollos en la fisiopatología, evaluación no invasiva y tratamiento

174.225

2004-2007

Bosch J

C03/02

Instituto de Salud Carlos III

Red Nacional de Investigación en Hepatología y Gastroenterología. Redes Temáticas de Investigación Cooperativa

1.463.126

2003-2006

Bosch J Instituto de Salud Carlos III

CIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD). Área de hipertensión portal y mecanismos de transición a cirrosis (Área 1)

5.120.000 2006

Bosch J PI05/1285 FIS Fisiopatología y nuevas formas de tratamiento de las enfermedades hepáticas, gastroenterológicas y pancreáticas

232.050 2005-2006

Bosch J PI06/0623 FIS Disfunción endotelial y actividad enos en la cirrosis. Mecanismo, significación y nuevas aplicaciones terapéuticas

289.795 2006

23

Malalties de l'Aparell Respiratori

Malalties de l'Aparell Respiratori - Publicacions 2006 Títol Autors Cita Original A new BAL fluid instillation and aspiration technique: a multicenter randomized study

Rosell A; Xaubet A; Agusti C; Castella J; Puzo C; Curull V; de Gracia J

Respiratory medicine; 2006 Mar; 100(3); p. 529-35

A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps.

Benitez P; Alobid I; de Haro J; Berenguer J; Bernal-Sprekelsen M; Pujols L; Picado C; Mullol J

The Laryngoscope; 2006 May; 116(5); p. 770-5

Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia

Dwyer R; Ortqvist A; Aufwerber E; Henriques Normark B; Marrie TJ; Mufson MA; Torres A; Woodhead MA; Alenius M; Kalin M

European journal of clinical microbiology & infectious diseases; 2006 Aug; 25(8); p. 518-21

Airway-centered interstitial fibrosis related to exposure to fumes from cleaning products

Serrano M; Molina-Molina M; Ramirez J; Sanchez M; Xaubet A

Archivos de bronconeumologia; 2006 Oct; 42(10); p. 557-9

Alexithymia: a relevant psychological variable in near-fatal asthma

Serrano J; Plaza V; Sureda B; de Pablo J; Picado C; Bardagi S; Lamela J; Sanchis J

The European respiratory journal; 2006 Aug; 28(2); p. 296-302

Bruix J PI050150 FIS Perfil de expresión génica en lesiones preneoplásicas y en el carcinoma hepatocelular inicial, en la cirrosis por el virus de la hepatitis C. Aplicación en la detección precoz y en el diagnóstico

??? 2006-2008

Gines P

PI050246

FIS

Complicaciones de la cirrosis en pacientes en candidatos a trasplante hepático. Diseño de nuevas estrategias para la reducción de la mortali8dad en lista de espera de trasplante hepático

155.890

2005-2008

Gines P SAF2005-01917

Dirección General de Investigación

Efecto de la hiponatremia sobre la función neuropsicológica en los pacientes con cirrosis. Mecanismos patogénicos e intervenciones terapéuticas

71.400 ???

Gines P PI050246 FIS Complicaciones de la cirrosis en pacientes en candidatos a trasplante hepático. Diseño de nuevas estrategias para la reducción de la mortalidad en lista de espera de trasplante hepático.

155.890 2005-2008

Navasa M PI050230

FIS Evolución de la recidiva de la infección por el virus de la hepatitis C en trasplante hepático de donante vivo. Comparación con el trasplante convencional. Papel de las lipoproteinas en la efectividad del virus de la hepatitis C

46.410

2005-2008

Panes J Asociación Española de Gastroenterología

Efectos de las variantes del gen CARD15/NOD2 sobre los mecanismos de apoptosis

12.000

2004-2006

Panes J

P/N: 503569

European Commission for Research: The Sixth Framework

Network of Excellence of European Molecular Imaging Laboratories (EMIL)

84.530

2004-2007

Panes J C03/02 Instituto Carlos III Red Nacional de investigación en hepatología y gastroenterología

126.000 2003-2006

Panes J SAF2006-03074

Ministerio E y C. Programa I+D

Análisis de expresión génica en la enfermedad inflamatoria intestinal: relación con el fenotipo, progresión de la enfermedad y respuesta al tratamiento

175.000 2006

Panes J PSE-010000-2006-6

Ministerio de E y C Proyectos Científico-Tecnológicos Singulares

Desarrollo de un kit diganóstico para las enfermedades inflamatorias mediadas por mecanismos inmunes (IMID-Kit)

1.850.000 2006-2010

24

Alpha-1-Antitrypsin Deficiency: Optimal Therapeutic Regime Based On Population Pharmacokinetics

Soy D, de la Roza C, Lara B, Esquinas C, Torres A Thorax, 2006; 61(12): 1059-64

Association between habitual naps and sleep apnea.

Masa JF; Rubio M; Perez P; Mota M; de Cos JS; Montserrat JM

Sleep; 2006 Nov 1; 29(11); p. 1463-8

Barcelona Smell Test - 24 (BAST-24): validation and smell characteristics in the healthy Spanish population

Cardesin A; Alobid I; Benitez P; Sierra E; de Haro J; Bernal-Sprekelsen M; Picado C; Mullol J

Rhinology; 2006 Mar; 44(1); p. 83-9

Bench Model To Simulate Upper Airway Obstruction for Analyzing Automatic Continuous Positive Airway Pressure Devices

Jordi Rigau, Josep M Montserrat, Holger Wöhrle, Diana Plattner, et al

Chest. Chicago: Aug 2006.Vol. 130, Iss. 2; pg. 350, 12 pgs

Changes in markers of epithelial permeability and inflammation in chronic smokers switching to a nonburning tobacco device (Eclipse)

Stewart JC; Hyde RW; Boscia J; Chow MY; O'Mara RE; Perillo I; Pietropaoli A; Smith CJ; Torres A; Utell MJ; Frampton MW;

Nicotine & tobacco research; 2006 Dec; 8(6); p. 773-83

Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units

Martinez JA; Nicolas JM; Marco F; Horcajada JP; Garcia-Segarra G; Trilla A; Codina C; Torres A; Mensa J

Critical care medicine; 2006 Feb; 34(2); p. 329-36

Control of ventilation, breathlessness perception and alexithymia in near-fatal asthma

Plaza V; Giner J; Picado C; Sureda B; Serrano J; Casan P; Pablo JD; Sanchis J

The Journal of asthma; 2006 Oct; 43(8); p. 639-44

Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease.

Chappell S; Daly L; Morgan K; Guetta Baranes T; Roca J; Rabinovich R; Millar A; Donnelly SC; Keatings V; MacNee W; Stolk J; Hiemstra P; Miniati M; Monti S; O'Connor CM; Kalsheker N

Human mutation; 2006 Jan; 27(1); p. 103-9

Depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index

Rabinovich RA; Ardite E; Mayer AM; Polo MF; Vilaro J; Argiles JM; Roca J

Respiration; international review of thoracic diseases; 2006; 73(6); p. 757-61

Differences in COPD care among doctors who control the disease: General practitioner vs. Pneumologist

García-Aymerich J, Escarrabill J, Marrades RM, Monsó E, Barreiro E, Antó JM, EFRAM investigators (Dr. A Torres como miembro del grupo)

Resp Med, 2006. 100: 332-9

Does Helicobacter pylori have a pathogenic role in bronchiectasis?

Angrill J; Sanchez N; Agusti C; Guilemany JM; Miquel R; Gomez J; Torres A

Respiratory medicine; 2006 Jul; 100(7); p. 1202-7

Early Noninvasive Ventilation Averts Extubation Failure in Patients at Risk: A Randomized Trial

Ferrer M; Valencia M; Nicolas JM; Bernadich O; Badia JR; Torres A

American journal of respiratory and critical care medicine; 2006 Jan 15; 173(2); p. 164

Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival

Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Xaubet A; Bernal-Sprekelsen M; Picado C

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology; 2006 Jan; 36(1); p. 52-8

Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome

Gomez FP; Barbera JA; Roca J; Burgos F; Gistau C; Rodriguez-Roisin R

Hepatology (Baltimore, Md); 2006 May; 43(5); p. 1084-91

Etiología y factores pronósticos de la neumonía adquirida en la comunidad en el adulto hospitalizado, Puerto Montt, Chile

Riquelme R, Riquelme M, Rioseco ML, Gómez V, Gil R, Torres A

Rev Med Chile, 2006; 134: 597-605

Experimental safety and efficacy evaluation of an extracorporeal pumpless artificial lung in providing respiratory support through the axillary vessels

Iglesias M; Jungebluth P; Sibila O; Aldabo I; Matute MP; Petit C; Torres A; Macchiarini P

The Journal of thoracic and cardiovascular surgery; 2007 Feb; 133(2); p. 339-45

25

Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis

Li X; Molina-Molina M; Abdul-Hafez A; Ramirez J; Serrano-Mollar A; Xaubet A; Uhal BD

merican journal of physiology Lung cellular and molecular physiology; 2006 Nov; 291(5); p. L887-95

Fungal pneumonia, chronic respiratory diseases and glucocorticoids

Agusti C; Rano A; Aldabo I; Torres A Medical mycology; 2006 Sep; 44 Suppl; p. 207-11

Hospitalized Community-Acquired Pneumonia Due to Streptococcus pneumoniae*: Has Resistance to Antibiotics Decreased?

Valles X; Marcos A; Pinart M; Piner R; Marco F; Mensa JM; Torres A

Chest; 2006 Sep; 130(3); p. 800

Identification of Vascular Progenitor Cells in Pulmonary Arteries of Patients with Chronic Obstructive Pulmonary Disease

Peinado VI; Ramirez J; Roca J; Rodriguez-Roisin R; Barbera JA

American journal of respiratory cell and molecular biology; 2006 Mar; 34(3); p. 257-63

Impact of Alcohol Abuse in the Etiology and Severity of Community-Acquired Pneumonia

de Roux A; Cavalcanti M; Marcos MA; Garcia E; Ewig S; Mensa J; Torres A

Chest; 2006 May; 129(5); p. 1219

Impact of initial antibiotic choice on mortality from pneumococcal pneumonia

Aspa J; Rajas O; Rodriguez de Castro F; Huertas MC; Borderias L; Cabello FJ; Tabara J; Hernandez-Flix S; Martinez-Sanchis A; Torres A

The European respiratory journal; 2006 May; 27(5); p. 1010-9

Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia

Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan J; Garnacho-Montero J; de la Torre MV; Sirvent JM; Bodi M

The European respiratory journal; 2006 Jun; 27(6); p. 1210-6

Influencia de las resistencias bacterianas sobre la eficiencia del tratamiento antibiótico de las agudizaciones de la bronquitis crónica en España

Sabés R, Segú JL, Puig-Junoy J, Torres A, Piñol C Pharmacoeconomics, 2006; 3 (3): 109-122

Integrated care prevents hospitalisations for exacerbations in COPD patients

Casas A; Troosters T; Garcia-Aymerich J; Roca J; Hernandez C; Alonso A; del Pozo F; de Toledo P; Anto JM; Rodriguez-Roisin R; Decramer M

The European respiratory journal; 2006 Jul; 28(1); p. 123-30

Integrating hospitals into community emergency preparedness planning

Braun BI; Wineman NV; Finn NL; Barbera JA; Schmaltz SP; Loeb JM

Annals of internal medicine; 2006 Jun 6; 144(11); p. 799

Is the incidence of near-fatal asthma decreasing in Spain?

Bellido Casado J; Plaza V; Bardagi S; Cosano J; Lopez Vina A; Martinez Moragon E; Rodriguez-Trigo G; Picado C; Sanchis J

Archivos de bronconeumologia; 2006 Oct; 42(10); p. 522-5

Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis

Molina-Molina M; Serrano-Mollar A; Bulbena O; Fernandez-Zabalegui L; Closa D; Marin-Arguedas A; Torrego A; Mullol J; Picado C; Xaubet A

Thorax; 2006 Jul; 61(7); p. 604-10


Cervera C; Agusti C; Angeles Marcos M; Pumarola T; Cofan F; Navasa M; Perez-Villa F; Torres A; Moreno A

Diagnostic microbiology and infectious disease; 2006 May; 55(1); p. 47-54

Mitochondrial dysfunction in copd patients with low body mass index

Rabinovich RA; Bastos R; Ardite E; Llinas L; Orozco-Levi M; Gea J; Vilaro J; Barbera JA; Rodriguez-Roisin R; Fernandez-Checa JC; Roca J

The European respiratory journal; 2006 Dec 20

Mixed community-acquired pneumonia in hospitalised patients

de Roux A; Ewig S; Garcia E; Marcos MA; Mensa J; Lode H; Torres A

The European respiratory journal; 2006 Apr; 27(4); p. 795-800

Mucin genes have different expression patterns in healthy and diseased upper airway mucosa

Martinez-Anton A; Debolos C; Garrido M; Roca-Ferrer J; Barranco C; Alobid I; Xaubet A; Picado C; Mullol J

Clinical and experimental allergy; 2006 Apr; 36(4); p. 448-57

Nonspecific interstitial pneumonia: epidemiologic and clinical characteristics

Reyes LJ; Morell F; Xaubet A; Ramirez J; Majo J Medicina clinica; 2006 Jan 21; 126(2); p. 47-52

Performance of mechanical ventilators at the patient's home: a multicentre quality control study

Farre R; Navajas D; Prats E; Marti S; Guell R; Montserrat JM; Tebe C; Escarrabill J

Thorax; 2006 May; 61(5); p. 400-4

26

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: is deep hypothermia required?

Macchiarini P; Kamiya H; Hagl C; Winterhalter M; Barbera JA; Karck M; Pomar J; Haverich A

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery; 2006 Aug; 30(2); p. 237-41; discussion 241-3

Quantifying plasma levels of transforming growth factor beta1 in idiopathic pulmonary fibrosis]

Molina-Molina M; Lario S; Luburich P; Ramirez J; Carrion MT; Xaubet A

Archivos de bronconeumologia; 2006 Aug; 42(8); p. 380-3

Recommendations for the use of equations to estimate glomerular filtration rate in adults. Spanish Society of Nephrology

Gracia S; Montanes R; Bover J; Cases A; Deulofeu R; Martin de Francisco AL; Orte LM

Nefrologia; 2006; 26(6); p. 658-65

Relation between rhinosinusitis and bronchiectasis

Guilemany JM; Mullol J; Picado C Archivos de bronconeumologia; 2006 Mar; 42(3); p. 135-40

Risk and prognostic factors of ventilator-associated pneumonia in trauma patients

Cavalcanti M; Ferrer M; Ferrer R; Morforte R; Garnacho A; Torres A

Critical care medicine; 2006 Apr; 34(4); p. 1067-72

Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment

Alobid I; Benitez P; Pujols L; Maldonado M; Bernal-Sprekelsen M; Morello A; Picado C; Mullol J

Rhinology; 2006 Mar; 44(1); p. 8-13

Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation

Martinez-Palli G; Gomez FP; Barbera JA; Navasa M; Roca J; Rodriguez-Roisin R; Burgos F; Gistau C

World journal of gastroenterology : WJG; 2006 Sep 28; 12(36); p. 5878-83

Systemic effects of cigarette smoke exposure in the guinea pig

Ardite E; Peinado VI; Rabinovich RA; Fernandez-Checa JC; Roca J; Barbera JA

Respiratory medicine; 2006 Jul; 100(7); p. 1186-94

Telemedicine experience for chronic care in COPD.

de Toledo P; Jimenez S; del Pozo F; Roca J; Alonso A; Hernandez C

IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society; 2006 Jul; 10(3); p. 567-73

The impact of atopy, sinus opacification, and nasal patency on quality of life in patients with severe nasal polyposis

Alobid I; Benitez P; Valero A; Berenguer J; Bernal-Sprekelsen M; Picado C; Mullol J

Otolaryngology--head and neck surgery; 2006 Apr; 134(4); p. 609-12

The impact of bronchiectasis associated to sinonasal disease on quality of life

Guilemany JM; Alobid I; Angrill J; Ballesteros F; Bernal-Sprekelsen M; Picado C; Mullol J

Respiratory medicine; 2006 Nov; 100(11); p. 1997-2003

The role of viruses in the aetiology of community-acquired pneumonia in adults

Angeles Marcos M; Camps M; Pumarola T; Antonio Martinez J; Martinez E; Mensa J; Garcia E; Penarroja G; Dambrava P; Casas I; Jimenez de Anta MT; Torres A

Antiviral therapy; 2006; 11(3); p. 351-9 SFX

Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis

Roca-Ferrer J; Pujols L; Gartner S; Moreno A; Pumarola F; Mullol J; Cobos N; Picado C

Thorax; 2006 Jul; 61(7); p. 592-6

Revisió A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis

Blasi F; Ewig S; Torres A; Huchon G Pulmonary pharmacology & therapeutics; 2006; 19(5); p. 361-9

ABS75: Asthma treatment in Spain - Study in primary care and Pneumology Services

Cimas JE; Coira G; Lopez-Vina A; Sanchez CD; Vegazo O; Picado C

Primary care respiratory journal : journal of the General Practice Airways Group; 2006 May 20;

Antibacterial dosage in intensive-care-unit patients based on pharmacokinetic/ pharmacodynamic principles

Soy D, Torres A Curr Opin Crit Care, 2006; 12 (5): 477-82

27

Antibiotic dosage regimens in respiratory tract infections in the pharmacokinetic /pharmacodynamic era

Soy D, Badia JR, Torres A Current Respiratory Medicine Reviews. 2006, 2: 89-7

Antibióticos en la exacerbación aguda de la EPOC ¿Qué lugar ocupa Cefditoren?

Martínez P, Torres A Med Clin Monogr, 2006, 7 (6): 327-338

Antibiotics for exacerbations of chronic obstructive pulmonary disease

Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC

Cochrane database of systematic reviews (Online); 2006 Apr 19; (2); p. CD004403

Associated inflammatory response in pneumonia: role of adjunctive therapy with glucocorticoids

Rano A; Agusti C; Sibila O; Torres A Current opinion in infectious diseases; 2006 Apr; 19(2); p. 179-84

Conducta y tratamiento en la neumonía adquirida en la comunidad

Martínez-Olondris P, Torres A Jano, 2006; 1595: 43-6

COPD exacerbations.5: management

Rodriguez-Roisin R Thorax; 2006 Jun; 61(6); p. 535-44

Formación troncal de las especialidades médicas; Un reto del presente para una mejora del sistema sanitario

Teres J, Capdevila JA, Nonell F, Cardellach F, Bundó M, Torres M (Torres A, como miembro y coautor de la Comisión de Medicina y Especialidades Relacionadas dels Consell Català d’Especialitats en Ciències de la Salut)

Med Clin (Barc), 2006; 127 (4): 139-44

Intermediate Respiratory Care Units Ferrer M, Martínez P, Torres A Clin Pulm Med, 2006; 13 (5): 1-7 Mechanisms of aspirin sensitivity Picado C Current allergy and asthma reports;

2006 May; 6(3); p. 198-202 Nosocomial pneumonia Ostendorf U; Ewig S; Torres A Current opinion in infectious diseases;

2006 Aug; 19(4); p. 327-38 Respiratory infections after lung cancer resection

Belda J, Cavalcanti M, Iglesias M, Gimferrer, JM, Torres A

Clin Pulmonary Med, 2006; 13 (1): 8-16

Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.

Picado C Expert opinion on pharmacotherapy; 2006 Oct; 7(14); p. 1989-2001

Surviving collapsed structure entrapment after earthquakes: a "time-to-rescue" analysis

Macintyre AG; Barbera JA; Smith ER Prehospital and disaster medicine; 2006 Jan-Feb; 21(1); p. 4-17; discussion 18-9

Tratamiento antimicrobiano de la enfermedad pulmonar obstructiva crónica en el anciano

Torres A, Quintano JA, Martínez M, Rodríguez C, Prieto J, Zalacaín R

Rev Esp Geriatr Gerontol, 2006; 41(6): 362-77

Tratamiento antimicrobiano de la enfermedad pulmonar obstructiva crónica en el anciano


Arch Bronconeumol, 2006; 42 (3): 1-15

Tratamiento antimicrobiano de la EPOC en el anciano


Rev Esp Quimioterap, 2006; 19 (2): 167-83

Treatment failure in patients with ventilator-associated pneumonia

Dominguez AA; Arango MV; Torres A Seminars in respiratory and critical care medicine; 2006 Feb; 27(1); p. 104-14

Two decades of imipenem therapy Rodloff AC, Goldstein EJC, Torres A J Antimicrobial Chemotherapy (JAC), 2006; 58(5): 916-29

Cas Clínic Pulmonary varix inside a bulla Sellares J; Santos S; Ballester E; Barbera JA Archivos de bronconeumologia; 2006

Jan; 42(1); p. 39-41 Tuberculosis, ancylostomiasis and eosinophilic pleural effusion

Rodriguez E; Delgado Y; Buges J; Bastida T; Torres M

Anales de medicina interna (Madrid, Spain : 1984); 2006 Jan; 23(1); p. 46-7

Editorial

28

Assessment of pneumonia severity: a European perspective

Ewig S; Torres A; Woodhead M The European respiratory journa; 2006 Jan; 27(1); p. 6-8

Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD

Celli B; Cross S; Grossman R; Kardos P; Myrseth SE; Rodriguez-Roisin R; Vestbo J

Primary care respiratory journal; 2006 Jun; 15(3); p. 139-42

Mortality in COPD patients with community-acquired pneumonia: who is the third partner?

Torres A; Menendez R The European respiratory journal; 2006 Aug; 28(2); p. 262-3

Respiratory infections after lung cancer resection

Torres A Expert review of anti-infective therapy; 2006 Oct; 4(5); p. 717-20

The new American Thoracic Society/Infectious Disease Society of North America guidelines for the management of hospital-acquired, ventilator-associated and healthcare-associated pneumonia: a current view and new complementary information

Torres A Current opinion in critical care; 2006 Oct; 12(5); p. 444-5

Llibre ¿Qué pacientes con neumonía adquirida en la comunidad debemos derivar al hospital para valorar ingreso hospitalario? Preguntas al experto sobre enfermedades infecciosas

Torres A, Dambrava P (1ª edición), 2006; 1: 99-106 ISBN: 84-690-0302-X

Casos Clínicos de residentes de Neumología y Cirugía Torácica 2005-2006

Álvarez-Sala JL, Torres A, Viejo JL ISBN: 84-7989-400-8. S.A. de Ediciones, Madrid (España), 2006

Clinical Criticare Care Medicine Albert R, Ranieri M, Takala J, Slutsky A, Torres A ISBN-13: 978-0-323-02844-8 ISBN-10: 0-323-02844-6 Editorial Elsevier 2006, Philadelphia, USA

Interacción cardiopulmonar y transporte gaseoso

Barberà J.A. Madrid: Sanitaria 2000, 2006.

Manual de auscultación pulmonar. Imágenes y sonidos en neumología

Ferrer M, Torres A ISBN:84-7877-428-9.Edikamed, Barcelona, 2006

Normativa sobre valoración del riesgo quirúrgico en el carcinoma broncogénico

Varela G., Barberà J.A., Cordovilla R., Duque J.L., López-Encuentra A., Puente L.

Barcelona: Doyma, 2006.

Respiratorio y atención primaria Torres A, Naberán K Depósito legal : B-950-06 JC Ediciones Médicas, S.L.. Barcelona (España), Vol 1:1, 2006

Técnicas y procedimientos en hipertensión pulmonar. Manual SEPAR de Procedimientos -10

Barberà J.A., Valera J.L., eds. Barcelona: Permanyer, 2006.

Woodhead M Respiratory Infections Torres A, Ewig S, Mandell L ISBN-10: 0-340-81694-5 ISBN-13: 978-0-340-81694-3 Editorial: Hodder Headline Group, 2006 Arnold, London, 2006

Capítol Llibre ¿Qué pacientes con neumonía adquirida en la comunidad debemos derivar al hospital para valorar ingreso hospitalario?

Torres A, Dambrava P

Preguntas al experto sobre enfermedades infecciosas (1ª edición), 2006; 1: 99-106 ISBN: 84-690-0302-X. Depósito Legal: M-35216-2006

29

Circulación pulmonar en la insuficiencia respiratoria

Pizarro S., Peinado V.I., Barberà J.A. En: De Lucas P., Güell R., Rodríguez J.M., Antón A., eds. Tratado de insuficiencia respiratoria. Madrid, SEPAR, 2006; 49-58.

Diagnostic approach in ventilator-associated pneumonia

Alcon A, Fábregas N, Torres A

En: Respiratory Infections. Torres A, Ewig S, Mandell L, Woodhead M ISBN-10: 0-340-81694-5. ISBN-13: 978-0-340-81694-3 Editorial: Hodder Headline Group, 2006. Capítulo 41.

Distrés respiratorio del adulto Sellarés J, Ferrer M, Torres A

En: Tratado de insuficiencia respiratoria. SEPAR. ISBN: 84-8473-498-6

Emergency treatment of community-acquired pneumonia.

Valencia M, Sellares J, Torres A

En: Respiratory Emergencies. Nava S, Welte T. Hardback ISBN:1-904097-38-3. Paperback ISBN: 1-904097-42-1 ISSN: 1025-448x European Respiratory Monograph. 2006; 36(11): 183-199

Enfermedades intersticiales difusas. Fiblosis pulmonary idiopática

Xaubet A En: Medicina Respiratoria 2ª edición. Ed. SEPAR. Editores: Martín P, Ramos G, Sanchis J Sección VIII Capitulo 54: 953-969 ISBN: 84-7885-401-0

Epidemiology of nosocomial respiratory infection

Bauer T, Torres A En: Respiratory Infections. Torres A, Ewig S, Mandell L, Woodhead M ISBN-10: 0-340-81694-5. ISBN-13: 978-0-340-81694-3 Editorial: Hodder Headline Group, 2006. Capítulo 38

Estudio hemodinámico pulmonar y prueba vasodilatadora aguda

Valera J.L., Melgosa M.T., Barberà J.A. En: Barberà J.A., Valera J.L., eds.Técnicas y procedimientos en hipertensión pulmonar. Manual SEPAR de Procedimientos – 10. Barcelona: Permanyer, 2006; 17-35.

Hipertensión pulmonar Barberà JA En: Alvarez-Sala J.L., Celli B., Torres A., eds. Enfermedades pulmonares vasculares. Respiratory disease self-assessment program. Medical Trends, 2006; 3-8.

Interacciones entre intercambio gaseoso pulmonar y periférico

Roca J En: Barberà J.A., ed. Interacción cardiopulmonar y transporte gaseoso. Madrid: Sanitaria 2000, 2006. 63-81

La proyección internacional de la SEPAR

Rodríguez-Roisin R

En: Historia de la neumología y la cirugía torácica españolas

La SEPAR del siglo XXI

Torres A

En: Historia de la neumología y cirugía torácica Española Editor: JL Álvarez Sala ISBN: 84-689-8759-X. Depósito Legal: M-23374-2006

Neumonía adquirida en la comunidad. Epidemiología, Etiología. Clínica.

Torres A

En: Medicina respiratoria, segunda edición. P. Martín, G. Ramos, J. Sanchis. ISBN: 84-7885-401-0. Depósito Legal: M-12702-2005 SEPAR. Aula medica, Barcelona, 2006; Capítulo 46.1: 817-830.

30

Neumonía intrahospitalaría

Torres A

En: Patología infecciosa respiratoria Depósito Legal: B-48.989.2004. Ed. Doyma Update, 2006

Non-invasive Ventilation for Respiratory Failure after Extubation.

Sellares J, Ferrer M, Torres A

En: 2006 Yearbook of Intensive Care and Emergency Medicine. Vincent JL. ISBN: 3-540-30155-0. Editorial Springer Verlag, Berlín (Alemania), 2006. Páginas: 494-501

Nosocomial Pneumonia Torres A, Valencia M, Sellarés J En: Encyclopedia of Respiratory Medicine, 2006

Nuevos retos en el tratamiento antibiótico de la Exacerbación de la EPOC.

Torres A En: 32 Simposio de Neumología. Asma y EPOC. Burgos, 20-21 oct de 2006: 55-68 Depósito Legal: BU-428-2006. Editor: J.L. Viejo Bañuelos

Pruebas de provocación nasal Bartra J, Valero AL, Picado C

En: Estudio de la función respiratoria. Ed. Sanitaria 2000. Pino JM, García F. ISBN: 84-611-2158-9. Cap. 5: 131-154.

Regulación del tono vascular pulmonar. En: Barberà J.A., ed. Interacción cardiopulmonar y transporte gaseoso

Peinado V.I., Barberà J.A. Madrid, Sanitaria 2000, 2006; 83-116.

Tratamiento de las agudizaciones de la EPOC

Soler L, Martinez P, Pizarro S, Torres A En: Infección 2004 Editores: Picazo JJ, Bouza E

Tratamiento en las infecciones respiratorias comunitarias.

Martínez-Olondris P, Pizarro S, Soler N, Torres A

En: Antimicrobianos en medicina. Prous Science. ISBN: 978-81-8124-240-9

Un nuevo paradigma: Utilidad potencial de los antibióticos en las agudizaciones del asma. El estudio Telicast.

Torres A

En: 32 Simposio de Neumología. Asma y EPOC. Burgos, 20-21 oct de 2006: 101-106 Depósito Legal: BU-428-2006. Editor: J.L. Viejo Bañuelos

Unidades de cuidados intermedios respiratorios

Ferrer M, Martinez-Olondris P, Torres A En: Tratado de insuficiencia respiratoria Editores: Pilar de Lucas, Rosa Güell, José Miguel Rodríguez, Antonio Antón ISBN: 84-8473-498-6

Ventilator-Associated Pneumonia Torres A, Alcón A, Fabregas N

En: Clinical Critical Care Medicine. Albert RK, Slutsky A, Ranieri M, Tácala J, Torres A ISBN: 0-323-02844-6. Editorial Elsevier, 2006. Capítulo 19. 175-186

Carta The SERPINE2 gene and chronic obstructive pulmonary disease

Chappell S; Daly L; Morgan K; Baranes TG; Roca J; Rabinovich R; Millar A; Donnelly SC; Keatings V; MacNee W; Stolk J; Hiemstra PS; Miniati M; Monti S; O'Connor CM; Kalsheker N

American journal of human genetics; 2006 Jul; 79(1); 184-6; author reply 186-7

31

Malalties de l'Aparell Respiratori - Projectes de recerca finançats 2006 Inv. Principal Ref. Ajut Entitat Títol Import € Durada Barberà JA PI041424 FIS Bases moleculares y celulares del daño vascular,

pulmonar y sistémico, asociado a situaciones de hipoxia continua o intermitente: implicaciones en la enfermedad pulmonar obstructiva cr´`onica y el síndrome de apneas durante el sueño.

140.875 2005-2007

Barberà JA PI050244 FIS Contribución de las celulas progenitoras vasculares en los mecanismos de reparación y remodelado de la circulación pulmonar en la enfermedad pulmonar obstructiva crónica

164.220 2005-2008

Barberà JA SLMM-CT-2005-018725

Unió Europea (6th FWP)

Pulmonary hipertensión: Functional genomics and therapy of lung vascular remodelling (PULMOTENSION)

315.677 2005-2009

Barberà JA PI031685 FIS Estudio epidemiológico de las repercusiones clínicas, funcionales y biológicas de la exposición al vertido de fuel del buque Prestige sobre la salud respiratoria en marineros de la costa de Galicia

485.300 2003-2006

Barberà JA 040310 Fundació La Marató de TV3

Estudi de la contribució de les cèl•lules progenitores vasculars en els mecanismes de lesió i reparació vascular a la circulació pulmonar en la malaltia pulmonar obstructiva crònica (MPOC)

140.000 2005-2008

Picado C PI050108 FIS Estudio de la relación entre la intolerancia a los antiinflamatorios no esteroideos y la producción de PGE2 con la gravedad del asma

119.000 2005-2008

Roca J PI050282 FIS Nuevos modelos de prestación de servicios sanitarios utilizando telemedicina

20.349 2005-2008

Roca J C510866 Unió Europea. Healt Telematics Program

SPEX (Spreading Excellence in healthcare) 124.636 2004-2006

Roca J C510743 Unió Europea. Healt Telematics Program

Ward in Hard 95.861 2004-2006

Roca J 508015 Unió Europea. Healt Telematics Program

Doc@Hand(Knowledge sharing and decision support for healthcare professionals)

228.400 2004-2006

Roca J 42010 La Marató de TV3 Atenció Integrada i biopatologia de la MPOC avançada 149.088 2005-2007

Roca J 517352 Unión Europea -eTEN HealthService24 - Continuous Mobile services for Healthcare

136.400 2005-2006

Roca J 517535 Unión Europea -eTEN LINKCARE -Linking Health Professionals in Emerging Care Environments

250.689 2005-2006

Roca J 017333

Unió Europea (6th FWP) Careman (Healthcare by Biosensor Measurements and Networking)

203.670 2005-2008

Roca J PI061510 FIS Entrenamiento muscular y actividad física en la EPOC

83.490 2006-2009

Roca J C029402

Unión Europea - eTEN Remote Health Monitoring with Wearable Non-Invasive Mobile System (HealthWear)

142.812 2006-2008

Roca J 037939 Unión Europea – FP6 Integrative Genomics and Chronic Disease Phenotypes: modelling and simulation tools for clinicians (BioBridge)

450.000 2006-2009

Torres A PI050136 FIS Modelo animal de neumonía asociada a la ventilación mecánica (NAVM). Estudio de la respuesta inflamatoria asociada y su modulación por glucocorticoides

121.618 2006-2009

Torres A CB06/06/0028 Instituto de Salud Carlos III

CIBER: enfermedades respiratorias

120.000 2006-2007

Torres A ?? FIS Contratos de apoyo a la Investigación del Sistema Nacional de Salud

24.000 2006-2009

Torres A ?? SEPAR Modelo animal de neumonía asociada a la ventilación mecánica (NAVM). Estudio de la respuesta inflamatoria asociada y su modulación por glucocorticoides

18.000 2006

32

Malalties del Sistema Endocrí i de la nutrició

Malalties Sistema Endocrí i de la nutrició - Publicacions 2006 Títol Autors Cita Original A FoxO-Smad synexpression group in human keratinocytes

Gomis RR; Alarcon C; He W; Wang Q; Seoane J; Lash A; Massague J

Proceedings of the National Academy of Sciences of the United States of America; 2006 Aug 22; 103(34); p. 12747-52

Análisis coste-utilidad de las bombas de insulina frente a múltiples dosis diarias de insulina en pacientes con Diabetes tipo I en España

Conget I, Rodríguez JM, Levy I, Castell C, Roze S, Serrano D

Rev. Esp. Salud Pública 2006;80:679-695

Assessment and control of metabolic and cardiovascular risk in patients with schizophrenia

Rodriguez-Artalejo F; Baca E; Esmatjes E; Merino-Torres JF; Monereo S; Moreno B; Mories T; Roca M; Salvador J; Sanmarti A

Medicina clinica; 2006 Oct 14; 127(14); p. 542-8

C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.

Gomis RR; Alarcon C; Nadal C; Van Poznak C; Massague J

Cancer cell; 2006 Sep; 10(3); p. 203-14

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.

Hoogma RP; Hammond PJ; Gomis R; Kerr D; Bruttomesso D; Bouter KP; Wiefels KJ; de la Calle H; Schweitzer DH; Pfohl M; Torlone E; Krinelke LG; Bolli GB

Diabetic medicine : a journal of the British Diabetic Association; 2006 Feb; 23(2); p. 141-7

Correlated mutations: advances and limitations. A study on fusion proteins an on the Cohesin-Dockerin families.

Halperin I, Wolfson H, Nussionov R. Proteins. 2006 Jun 1;63(4):832-45.

Effect of ramipril on the incidence of diabetes

The DREAM trial investigators (I Conget, Steering Committee)

N. Engl. J. Med. 2006;114:1551-62

Effect of rosiglitazone on the requency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

The DREAM trial investigators (I Conget, Steering Committee)

Lancet 2006;368:1096-105

Estrategias para un control eficaz de la hipertensión arterial en España. Documento de consenso.

Coca A, Aranda P, Bertnomeu V, Bonet A, Esmatjes E, Guillén F, Hernández J, Llisterri JL, Marín R, Megía C, Rodríguez L.

Semergen 2006;32(7):330-333.

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

Morinigo R; Lacy AM; Casamitjana R; Delgado S; Gomis R; Vidal J

Obesity surgery : the official journal of the American Society for Bariatric Surgery and of the Obesity Surgery Society of Australia and New Zealand; 2006 Dec; 16(12); p. 1594-601

Hepatitis C virus and splenic marginal zone lymphoma with villous lymphocytes: Hawai from conventional therapy.

Gurvits GE, Matan R, Halperin I. Scand. J. Gastroenterol. 2007 Jul 20;1-2

Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes.

Musri MM; Corominola H; Casamitjana R; Gomis R; Parrizas M

The Journal of biological chemistry; 2006 Jun 23; 281(25); p. 17180-8

33

Improving metabolic control in sub-optimally controlled subjects wity Type 1 diabetes: comparison of two tretament algorithms using insulin glargine.

Gomis R, Storms F, Conget I, Sinnassamy P, Davies M.

Diab. Res. Clin. Pract . 2006

Inhibition of GSK3 dependent tau phosphorylation by metals

Gomez-Ramos A; Dominguez J; Zafra D; Corominola H; Gomis R; Guinovart JJ; Avila J

Current Alzheimer research; 2006 Apr; 3(2); p. 123-7

Intra-abdominal fat adiponectin receptors expresión and cardiovascular metabolic risk factors in obesity and diabetes.

Morinigo R, Musri M, Vidal J, Casamitjana R, Delgado S, Laci AM, Ayuso C, Gomis R, Corominola H.

Obes. Surg. 16(6):745-751

Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes

Morinigo R; Musri M; Vidal J; Casamitjana R; Delgado S; Lacy AM; Ayuso C; Gomis R; Corominola H

Obesity surgery : the official journal of the American Society for Bariatric Surgery and of the Obesity Surgery Society of Australia and New Zealand; 2006 Jun; 16(6); p. 745-51

Nefropatía diabética: de la hiperfiltración glomerular al trasplante renal.

Esmatjes E. Avances en diabetología 2006;22(2):2-4.

Prognostic significance of the white coat hypertension in patients with type 1 diabetes mellitus

Flores L; Gimenez M; Esmatjes E Diabetes research and clinical practice; 2006 Oct; 74(1); p. 21-5

Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation.

Gomez-Ramos A; Dominguez J; Zafra D; Corominola H; Gomis R; Guinovart JJ; Avila J

Journal of neuroscience research; 2006 Feb 1; 83(2); p. 264-73

Strategies for effective control of arterial hipertensión in Spain. Consensus document

Coca A, Aranda P, Bertomeu V, Bonet A, Esmatjes E, Guillén F, Hernández-Moreno J, Llisterri JL, Marín-Iranzo R, Megia C, Rodríguez-Manas L, Suárez C.

Rev. Clin. Esp. 2006 Nov; 2006(10): 510-4

Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control

Jansa M; Vidal M; Viaplana J; Levy I; Conget I; Gomis R; Esmatjes E

Diabetes research and clinical practice; 2006 Oct; 74(1); p. 26-32

Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control.

Jansa M; Vidal M; Viaplana J; Levy I; Conget I; Gomis R; Esmatjes E

2006 Oct; 74(1); p. 26-32

The logic of TGFbeta signaling Massague J; Gomis R FEBS letters; 2006 May 22; 580(12); p. 2811-20

Therapeutic educations seminars for patines.

Vidal M, Jansà M, Levy I, Jiménez M, Herrera F, Lorente I, Marín MC, Oriell J, Sanhonorato J, Sanz O, Conget I.

Eur. Diabetes Nursing 2006:3:132-136.

Treatment and control of cardiovascular risk in primary care in Spain. The PREVENCAT study

Coca A; Dalfo A; Esmatjes E; Llisterri JL; Ordonez J; Gomis R; Gonzalez-Juanatey JR; Martin-Zurro A

Medicina clinica; 2006 Feb 18; 126(6); p. 201-5

Young adult onset diabetes mellitus. Clinical differences between MODY-3 and type 2 diabetes mellitus

Conget I; Gimenez M; Nicolau J; Costa A; Oriola J; Casamitjana R;

Medicina clinica; 2006 May 6; 126(17); p. 651-2

Revisió Algoritmo terapéutico de la Diabetes mellitus tipo 1.

Giménez M, Conget I. Endocrinol. Nutr. 2006;53 (Supl. 2):4-6.

Endocrine evaluation of patients after brain injury: what else is needed to define specific clinical recommendations?

Sesmilo G, Halperin I, Puig-Domingo M. Hormones (Athens). 2007 Apr-Jun;6(2):132-7.

34

La prevención de la diabetes mellitus de tipo 2 ¿realidad o sueño? A propósito de los resultados del estudio DREAM.

Conget I, Giménez M. Av. Diabetol. 2006;22:112-114.

Mild cognitive impairment (MCI): characteristics, risk factors and prevention

Halperin I, Korczyin AD Harefuah. 2006 Mar;145(3):229-34,243.

Síndrome metabólico. Definición y epidemiología.

Giménez M, Nicolau J, Conget I. Rev. Clin.Esp. 2006;206 (Supl. 1) 3-6.

Carta Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route

Conget I; Piquer S; Julia M; Gomis R; Esmatjes E; Garcia-Pagan JC; Bosch J; Gilabert R; Ricart MJ; Fernandez-Cruz L; Manyalich M

Transplantation; 2006 Apr 27; 81(8); p. 1220-1

Llibre La fi de la diabetes? Cèl.lules mare, l’esperança de la biomedicina.

Gomis R. Edicions Bromera-Publicacions Univ. De Valencia-Càtedra de divulgació de la Ciencia. Alzira, 2006.

Prediabetes y diabetes tipo 1 de reciente diagnóstico.

Conget I. (Coordinador) Biblioteca de la Sociedad Española de Diabetes. Sociedad Española de Diabetes-Ediciones Mayo. Barcelona, 2006.

Capítol Llibre Prólogo. Pie diabético. Conget I. En: Guía práctica para la prevención,

evaluación y tratamiento.J Viadé. Ed. Panamericana. Madrid, 2006

Malalties del Sistema Endocrí i de la Nutrició - Projectes Finançats 2006 Investigador Principal Referència Ajut Entitat Nom Projecte Import Durada Conget I Ajut Contracte associat a

projecte de recerca Hospital Clínic i Universitari

Sistemas de infusión subcutánea continua de insulina y de monitorización continua de la glucosa en la Diabetes de Tipo 1. Efecto sobre el perfil de riesgo cardiovascular de los pacientes con control lábil por hipoglucemias recurrentes y severas.

24.000 2006-2009

Conget I PI060250 FIS Sistemas de infusión subcutánea continua de insulina y de monitorización continua de la glucosa en la Dibetes de Tipo 1. Efecto sobre el perfil de riesgo cardiovascular de los pacientes con control lábil por hipoglucemias recurrentes y severas.

57.475 2006-2009

Esmatjes E PI070124 FIS Efectos del by-pass gástrico sobre la presión arterial y la disfunción endotelial en personas con obesidad grave

44.770 2006

Gomis R CE503245-0 CEE Coordination action on the aetiology, pathology and prediction of type 1 diabetes in Europa (TONECA)

32.957,60 2004 -2008

Gomis R RD06/0015/00 FIS REDIMET-Red de diabetes y enfermedades metabólicas asociadas 450.000 2007-2010 Gomis R 2005SGR00019 ? Diabetes i alteracions metabòliques. Investigació cel.lular i molecular

en diabetis i obesitat 50.600 2005-2008

Gomis R Genoma_ES 06/409 ? Banco Nacional de ADN-Nodo de Metabólicas 212.677 2006-2009 Gomis R PI042553 FIS Efecto del tungstato sobre el síndrome metabólico: dianas moleculares 106.950 2005-2007 Gomis R PI051264 FIS Defectos moleculares en la diabetes mellitus: terapia genética y

celular. 41.769 2006

Gomis R 051241 FIS Biocomunicación celular y redes moleculares en enfermedades metabólicas

136.255 2006

Gomis R SAF2006-07382 ? Dianas moleculares inducidas por tungstato en la obesidad 677.600 2006-2011 Gomis R LSHM-CT-2004-503245 ? Coordinated action on the aetiology, pathology and prediction of type 1

diabetes in Europe (TONECA) 33.500 2004-2008

35

Malalties del Sistema Excretor Renal i Genital Masculí

Malalties del Sistema Excretor Renal i Genital Masculí - Publicacions 2006 Títol Autors Cita Original Automedida de la presión arterial domiciliaria. Influencia del sistema de cáculo de la media en el diagnóstico de la Hipertensión de bata blanca

J. Bayó, C. Roca, A. Dalfó, MM Martin-Baranera, KX Naberan, A. Botey

Aten Primaria 2006;38:212-8

Catastrophic antiphospholipid syndrome presenting with renal thrombotic microangiopathy and diffuse proliferative glomerulonephritis

Gomez-Puerta JA; Salgado E; Cervera R; Aguilo S; Ramos-Casals M; Soler M; Torras A; Font J

Clinical and experimental rheumatology; 2006 Jan-Feb; 24(1); p. 110

Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria

Saurina A; Campistol JM; Piera C; Diekmann F; Campos B; Campos N; de las Cuevas X; Oppenheimer F

Nephrology, dialysis, transplantation; 21(2); p. 488-93

Does losartan alter urinary levels of connective tissue growth factor in patients with diabetic nephropathy?

Campistol JM Nature clinical practice Nephrology; 2006 Apr; 2(4); p. 192-3

Gastrointestinal stromal tumors Darnell A; Dalmau E; Pericay C; Musulen E; Martin J; Puig J; Malet A; Saigi E; Rey M

Abdominal imaging; 2006 Jul-Aug; 31(4); p. 387

Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version

Marin R; Goicoechea MA; Gorostidi M; Cases A; Diez J; Escolar G; Fernandez-Vega F; Palomar R; Rodrigo E; Martinez I; Segura J

Nefrologia; 2006; 26(1); p. 31-44

Home blood presure self-monitoing: diagnostic performance in white-coat hypertension

J. Bayó, FX Cos, C. Roca, A. Dalfó, MM Martín-Baranera, A. Botey

Blood Presure Monitoring 2006; 11:47-52

Implication of chromosome 18 in hypertension by sibling pair and association analyses: putative involvement of the RKHD2 gene

Guzman B; Cormand B; Ribases M; Gonzalez-Nunez D; Botey A; Poch E

Hypertension; 2006 Nov; 48(5); p. 883-91

Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction

Ruiz JC; Campistol JM; Sanchez-Fructuoso A; Rivera C; Oliver J; Ramos D; Campos B; Arias M; Diekmann F

Nephrology, dialysis, transplantation 2006 Nov; 21(11); p. 3252-7

Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years

Marcen R; Morales JM; del Castillo D; Campistol JM; Seron D; Valdes F; Anaya F; Andres A; Arias M; Bustamante J; Capdevila L; Escuin F; Gil-Vernet S; Gonzalez-Molina M; Lampreave I; Oppenheimer F; Pallardo L

Transplantation proceedings; 2006 Dec; 38(10); p. 3530-2

Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients

Andres V; Castro C; Campistol JM Nephrology, dialysis, transplantation: 2006 Jul; 21 Suppl 3; p. iii14-7

Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study

Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A

Nephrology, dialysis, transplantation; 2006 Feb; 21(2); p. 459-65

36

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation

Campistol JM; Eris J; Oberbauer R; Friend P; Hutchison B; Morales JM; Claesson K; Stallone G; Russ G; Rostaing L; Kreis H; Burke JT; Brault Y; Scarola JA; Neylan JF

Journal of the American Society of Nephrology : JASN; 2006 Feb; 17(2); p. 581-9

Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?

Puig J; Darnell A; Bermudez P; Malet A; Serrate G; Bare M; Prats J

European radiology; 2006 Apr; 16(4); p. 939-43

Treatment of hepatitis C in hemodialysis patients and renal transplant recipients

Barrera J; Campistol JM Gastroenterologia y hepatologia; 2006 Oct; 29 Suppl 2; p. 158-62

Usefulness of 111In-oxine labelled platelets in the management of febrile syndrome in dialysis patients with non-functional renal allografts

Ortin-Perez J; Fuster D; Lomena F; Torregrosa JV; Piera C; Rodriguez-Puig D; Duch J; Rubi S; Setoain X; Campistol JM; Pons F

Revista espanola de medicina nuclear; 2006 Sep; 25(5); p. 289-93

Revisió Chronic transplant nephropathy Hernandez D; Sanchez Fructuoso A; Seron D; Arias

M; Campistol JM; Morales JM; Alonso A; Andres A; del Castillo D; Gentil MA; Gonzalez-Molina M; Gonzalez Posada JM; Moreso F; Oppenheimer F; Pallardo LM; Sola R

Nefrologia; 2006; 26 Suppl 1; p. 1-38

Cas Clínic Renal cortical necrosis after kidney transplantation associated with the prothrombin 20210A mutation

Quintana LF; Cofan F; Reverte JC; Oppenheimer F; Campistol JM

Nephrology, dialysis, transplantation; 2006 May; 21(5); p. 1455-6

Editorial A year of advancement and reflection in nephrology science

Cases A Drug news & perspectives; 2006 Mar; 19(2); p. 121-7

Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks

Diekmann F; Campistol JM Nephrology, dialysis, transplantation; 2006 Mar; 21(3); p. 562-8

Malalties del Sistema Nerviós

Malalties del Sistema Nerviós - Publicacions 2006 Títol Autors Cita Original 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism

Gaig C; Marti MJ; Tolosa E; Valldeoriola F; Paredes P; Lomena FJ; Nakamae F

Movement disorders; 2006 Nov; 21(11); p. 1994-8

Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice

Justicia C; Martin A; Rojas S; Gironella M; Cervera A; Panes J; Chamorro A; Planas AM

Journal of cerebral blood flow and metabolism; 2006 Mar; 26(3); p. 421-32

Blood lead levels in children and environmental lead contamination in Miami inner city, Florida

Gasana J; Hlaing WM; Siegel KA; Chamorro A; Niyonsenga T

International journal of environmental research and public health; 2006 Sep; 3(3); p. 228-34

Characterization of a conduit system containing laminin-5 in the human thymus: a potential transport system for small molecules

Drumea-Mirancea M; Wessels JT; Muller CA; Essl M; Eble JA; Tolosa E; Koch M; Reinhardt DP; Sixt M; Sorokin L; Stierhof YD; Schwarz H; Klein G

Journal of cell science; 2006 Apr 1; 119(Pt 7); p. 1396-405

CLEAR-test: Combining inference for differential expression and variability in microarray data analysis

Valls J; Grau M; Sole X; Hernandez P; Montaner D; Dopazo J; Peinado MA; Capella G; Moreno V; Pujana MA

Journal of biomedical informatics; 2007 May 17

37

Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials?

Vargas M; Horcajada JP; Obach V; Revilla M; Cervera A; Torres F; Planas AM; Mensa J; Chamorro A

Stroke; a journal of cerebral circulation; 2006 Feb; 37(2); p. 461-5

Effect of glatiramer acetate (Copaxone) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: a longitudinal study

Blanco Y; Moral EA; Costa M; Gomez-Choco M; Torres-Peraza JF; Alonso-Magdalena L; Alberch J; Jaraquemada D; Arbizu T; Graus F; Saiz A

Neuroscience letters; 2006 Oct 9; 406(3); p. 270-5

EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force

Soffietti R; Cornu P; Delattre JY; Grant R; Graus F; Grisold W; Heimans J; Hildebrand J; Hoskin P; Kalljo M; Krauseneck P; Marosi C; Siegal T; Vecht C

European journal of neurology; 2006 Jul; 13(7); p. 674-81

End-of-dose wearing off in Parkinson disease: a 9-question survey assessment

Stacy M; Hauser R; Oertel W; Schapira A; Sethi K; Stocchi F; Tolosa E

Clinical neuropharmacology; 2006 Nov-Dec; 29(6); p. 312-21

Evidence for systems-level molecular mechanisms of tumorigenesis

Hernandez P; Huerta-Cepas J; Montaner D; Al-Shahrour F; Valls J; Gomez L; Capella G; Dopazo J; Pujana MA

BMC genomics; 2007 Jun 20; 8; p. 185

Health-related quality of life in multiple system atrophy

Schrag A; Geser F; Stampfer-Kountchev M; Seppi K; Sawires M; Kollensperger M; Scherfler C; Quinn N; Pellecchia MT; Barone P; Del Sorbo F; Albanese A; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Nilsson CF; Widner H; Lindvall O; Giladi N; Gurevich T; Dan

Movement disorders; 2006 Jun; 21(6); p. 809-15

Increase in body weight after pramipexole treatment in Parkinson's disease.

Kumru H; Santamaria J; Valldeoriola F; Marti MJ; Tolosa E

Movement disorders 2006 Nov; 21(11); p. 1972-4

Individual-based model and simulation of Plasmodium falciparum infected erythrocyte in vitro cultures

Ferrer J; Vidal J; Prats C; Valls J; Herreros E; Lopez D; Giro A; Gargallo D

Journal of theoretical biology; 2007 Oct 7; 248(3); p. 448-59

Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke

Chamorro A; Amaro S; Vargas M; Obach V; Cervera A; Torres F; Planas AM

Journal of neurology, neurosurgery, and psychiatry; 2006 Nov; 77(11); p. 1279-81

LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance

Gaig C; Ezquerra M; Marti MJ; Munoz E; Valldeoriola F; Tolosa E

Archives of neurology; 2006 Mar; 63(3); p. 377

Management of paraneoplastic neurological syndromes: report of an EFNS Task Force

Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R

European journal of neurology; 2006 Jul; 13(7); p. 682-90

Modest MRI signal intensity changes precede delayed cortical necrosis after transient focal ischemia in the rat

Rojas S; Martin A; Justicia C; Falcon C; Bargallo N; Chamorro A; Planas AM

Stroke; a journal of cerebral circulation; 2006 Jun; 37(6); p. 1525-32

Neuro-oncology: setting new standards of management

Graus F; Tortosa A Lancet neurology; 2006 Jan; 5(1); p. 8-9

Neuropsychological deficits in Parkinson's disease patients with visual hallucinations

Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E

Movement disorders; 2006 Sep; 21(9); p. 1483-7

No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis

Blanco Y; Gomez-Choco M; Arostegui JL; Casanova B; Martinez-Rodriguez JE; Bosca I; Munteis E; Yague J; Graus F; Saiz A

Neuroscience letters; 2006 Apr 3; 396(3); p. 217-9

38

No evidence of CRHR1 gene involvement in progressive supranuclear palsy

Campdelacreu J; Gaig C; Ezquerra M; Munoz E; Marti MJ; Valldeoriola F; Tolosa E

Neuroscience letters; 2006 Nov 27; 409(1); p. 61-4

Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)

Geser F; Wenning GK; Seppi K; Stampfer-Kountchev M; Scherfler C; Sawires M; Frick C; Ndayisaba JP; Ulmer H; Pellecchia MT; Barone P; Kim HT; Hooker J; Quinn NP; Cardozo A; Tolosa E; Abele M; Klockgether T; Ostergaard K; Dupont E; Schimke N; Eggert KM; Oe

Movement disordersy; 2006 Feb; 21(2); p. 179-86

Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer

Sabater L; Bataller L; Carpentier AF; Aguirre-Cruz ML; Saiz A; Benyahia B; Dalmau J; Graus F

Journal of neurology, neurosurgery, and psychiatry; 2006 Dec; 77(12); p. 1359-62

Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis

Iranzo A; Graus F; Clover L; Morera J; Bruna J; Vilar C; Martinez-Rodriguez JE; Vincent A; Santamaria J

Annals of neurology; 2006 Jan; 59(1); p. 178-81

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

Iranzo A; Molinuevo JL; Santamaria J; Serradell M; Marti MJ; Valldeoriola F; Tolosa E

Lancet neurology; 2006 Jul; 5(7); p. 572-7

Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode

Pintor L; Bailles E; Valldeoriola F; Tolosa E; Marti MJ; de Pablo J

General hospital psychiatry; 2006 Jan-Feb; 28(1); p. 59-64

Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson's disease

Lees AJ; Ratziu V; Tolosa E; Oertel WH Journal of neurology, neurosurgery, and psychiatry; 2007 Sep; 78(9); p. 944-8

The alpha-synuclein gene in multiple system atrophy

Ozawa T; Healy DG; Abou-Sleiman PM; Ahmadi KR; Quinn N; Lees AJ; Shaw K; Wullner U; Berciano J; Moller JC; Kamm C; Burk K; Josephs KA; Barone P; Tolosa E; Goldstein DB; Wenning G; Geser F; Holton JL; Gasser T; Revesz T; Wood NW

Journal of neurology, neurosurgery, and psychiatry; 2006 Apr; 77(4); p. 464-7

The harms and benefits of inflammatory and immune responses in vascular disease

Chamorro A; Hallenbeck J Stroke; a journal of cerebral circulation; 2006 Feb; 37(2); p. 291-3

Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.

Romanos E; Planas AM; Amaro S; Chamorro A Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism; 2007 Jan; 27(1); p. 14-20

WAERS: an application for Web-assisted estimation of relative survival

Cleries R; Valls J; Esteban L; Galvez J; Pareja L; Sanz X; Alliste L; Martinez JM; Moreno V; Bosch X; Borras JM; Ribes JM

Medical informatics and the Internet in medicine; 2007 Sep; 32(3); p. 169-75

Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Role of corticosteroids, inflammation, and protein O-glycosylation

Martin A; Rojas S; Chamorro A; Falcon C; Bargallo N; Planas AM;

Stroke; a journal of cerebral circulation; 2006 May; 37(5); p. 1288-95

Revisió Dystonia in Parkinson's disease Tolosa E; Compta Y Journal of neurology; 2006 Dec; 253

Suppl 7; p. VII7-13 Immediate anticoagulation for acute stroke in atrial fibrillation: yes

Chamorro A Stroke; a journal of cerebral circulation; 2006 Dec; 37(12); p. 3052-3

39

Residues from veterinary medicinal products, growth promoters and performance enhancers in food-producing animals: a European Union perspective

Serratosa J; Blass A; Rigau B; Mongrell B; Rigau T; Tortades M; Tolosa E; Aguilar C; Ribo O; Balague J

Revue scientifique et technique (International Office of Epizootics); 2006 Aug; 25(2); p. 637-53

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease

Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen JP; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C

European journal of neurology; 2006 Nov; 13(11); p. 1186-202

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.

Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen JP; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C

European journal of neurology; 2006 Nov; 13(11); p. 1170-85

Signalling pathways mediating inflammatory responses in brain ischaemia

Planas AM; Gorina R; Chamorro A Biochemical Society transactions; 2006 Dec; 34(Pt 6); p. 1267-70

The diagnosis of Parkinson's disease

Tolosa E; Wenning G; Poewe W Lancet neurology; 2006 Jan; 5(1); p. 75-86

Thymus and myasthenia gravis: antigen processing in the human thymus and the consequences for the generation of autoreactive T cells

Melms A; Luther C; Stoeckle C; Poschel S; Schroth P; Varga M; Wienhold W; Tolosa E

Acta neurologica Scandinavica Supplementum; 2006; 183; p. 12-3

Cas clínic de Andres C; Esquivel A; de Villoria JG; Graus F; Sanchez-Ramon S

de Andres C; Esquivel A; de Villoria JG; Graus F; Sanchez-Ramon S


MM1 variant of sporadic Creutzfeldt-Jakob disease with long duration akinetic mutism state

Sanchez-Valle R; Santamaria J; Rey MJ; Rodriguez A; Graus F; Saiz A

Neurologia (Barcelona, Spain); 2006 Oct; 21(8); p. 444-6

NMO-IgG antibodies in neuromyelitis optica: a report of 2 cases

Zuliani L; Lopez de Munain A; Ruiz Martinez J; Olascoaga J; Graus F; Saiz A

Neurologia (Barcelona, Spain); 2006 Jul-Aug; 21(6); p. 314-7

Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies

Hernandez-Echebarria L; Saiz A; Ares A; Tejada J; Garcia-Tunon L; Nieves C; Graus F

Neurology; 2006 Feb 14; 66(3); p. 450-1

Pure autonomic failure with altered dopamine transporter imaging

Compta Y; Marti MJ; Paredes P; Tolosa E Archives of neurology; 2006 Apr; 63(4); p. 604

Carta Cognitive changes in Parkinson's disease during subthalamic stimulation: a clinicopathologic study

Valldeoriola F; Tolosa E; Alegret M; Tolosa E; Rey MJ; Morsi O; Pilleri M; Rumia J


Hu-antibody-positive patients with or without cancer have similar clinical profiles

Llado A; Carpentier AF; Honnorat J; Sillevis-Smitt P; Twijnstra A; Blanco Y; Hart IK; Saiz A; Graus F

Journal of neurology, neurosurgery, and psychiatry; 2006 Aug; 77(8); p. 996-7

40

Intronic c.573 + 79G>A polymorphism of protein Z gene in haemorrhagic and ischaemic stroke

Obach V; Munoz X; Sala N; Garcia de Frutos P; Chamorro A

Thrombosis and haemostasis; 2006 Jun; 95(6); p. 1040-1

Malalties Infeccioses

Malalties Infeccioses - Publicacions 2006 Titol Autors Cita Original A prospective survey of Human Herpesvirus-6 primary infection in solid organ transplant recipients

Cervera C, Marcos MA, Linares L, Roig E, Benito N, Pumarola T, Moreno A

Transplantation. 2006;82:979-982

A Review of Critical Periods for Opportunistic Infection in the New Transplantation Era

R San Juan Garrido, JM Aguado, C Diaz-Pedroche, O len, M Montejo, A Moreno, M Gurguí, J Torres-Cisneros, F Pareja, J Segovia, M García, C Lumbreras

Transplantation 2006; 82: 1457-1462

An integral care telemedicine system for HIV/AIDS patients.

Caceres C; Gomez EJ; Garcia F; Gatell JM; del Pozo F

International journal of medical informatics; 2006 Sep; 75(9); p. 638-42

Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutations

Blanco JL; Biglia A; De Lazzari E; Mallolas J; Martinez E; Pumarola T; Larrousse M; Milinkovic A; Leon A; Lonca M; Laguno M; Gatell JM

AIDS (London, England); 2006 Sep 11; 20(14); p. 1891-2

Antiretroviral therapy of HIV infection: duration and reasons for changing the first therapeutic regimen in 518 patients

Gratacos L; Tuset M; Codina C; Miro JM; Mallolas J; Miserachs N; Martin-Conde MT; del Cacho E; Lazzari E; Ribas J; Gatell JM


Aorto-Cavitary Fistula in Endocarditis Working Group. Periannular complications in infective endocarditis involving native aortic valves

Anguera I, Miro JM, Evangelista A, Cabell CH, San Roman JA, Vilacosta I, Almirante B, Ripoll T, Farinas MC, Anguita M, Navas E, Gonzalez-Juanatey C, Garcia-Bolao I, Munoz P, de Alarcon A, Sarria C, Rufi G, Miralles F, Pare C, Fowler VG Jr, Mestres CA, de Lazzari E, Guma JR, Moreno A et al.

Am J Cardiol. 2006 Nov 1;98(9):1254-60

Aorto-Cavitary Fistula in Endocarditis Working Group. Periannular complications in infective endocarditis involving prosthetic aortic valves

Anguera I, Miro JM et al. Am J Cardiol. 2006 Nov 1;98(9):1261-8

Behcet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy

Gomez-Puerta JA, Espinosa G, Miro JM, Sued O, Llibre JM, Cervera R, Font J

Isr Med Assoc J. 2006 Jul;8(7):513-4

Cardiac surgery in human immunodeficiency virus positive patients

Mestres CA, Miro JM Ind J Thorac Cardiovasc Surg. 2006; 22:203-204

Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002

Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN

Archives of internal medicine; 2006 Mar 13; 166(5); p. 521

Comparison of single and boosted protease inhibitor versus nonnucleoside reverse transcriptase inhibitor-containing cART regimens in antiretroviral-naive patients starting cART after January 1, 2000

Gatell JM, Miro JM, Zamora L HIV Clin Trials. 2006 Nov-Dec;7(6):271-84

41

Complications of Native and Prosthetic Valve Infective Endocarditis: Update in 2006

Anguera I, Del Rio A, Moreno A, Pare C, Mestres CA, Miro JM

Curr Infect Dis Rep. 2006 Jun;8(4):280-8

Complications of Native andProsthetic Valve Infective Endocarditis: Update in 2006

Anguera I; Del Rio A; Moreno A; Pare C; Mestres CA; Miro JM

Current infectious disease reports; 2006 Jun; 8(4); p. 280-8

Cryopreserved mitral homograft in the tricuspid position for infective endocarditis: a valve that can be repaired in the long-term (13 years)

Mestres CA, Castella M, Moreno A, Pare JC, del Rio A, Azqueta M, Fernandez C, Miro JM, Pomar JL

J Heart Valve Dis. 2006 May;15(3):389-91

Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART.

Coll O; Suy A; Figueras F; Vernaeve V; Martinez E; Mataro D; Durban M; Lonca M; Vidal R; Gatell JM

AIDS (London, England); 2006 Jan 2; 20(1); p. 121-3

Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial

Miro JM, Lopez JC, Podzamczer D, Pena JM, Alberdi JC, Martinez E, Domingo P, Cosin J, Claramonte X, Arribas JR, Santin M, Ribera E; GESIDA 04/98 Study Group

Clin Infect Dis. 2006 Jul 1;43(1):79-89

Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients.

Libois A; Lopez A; Garcia F; Castro P; Maleno MJ; Garcia A; Climent N; Arnedo M; Gallart T; Gatell JM; Plana M

AIDS research and human retroviruses;2006 Jul; 22(7); p. 657-66

Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort

Berenguer J; Perez-Elias MJ; Bellon JM; Knobel H; Rivas-Gonzalez P; Gatell JM; Miguelez M; Hernandez-Quero J; Flores J; Soriano V; Santos I; Podzamczer D; Sala M; Camba M; Resino S;

Journal of acquired immune deficiency syndromes (1999); 2006 Feb 1; 41(2); p. 154-9

Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting

Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonca J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA

HIV medicine; 2006 Apr; 7(3); p. 146-55

Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study

Gatell JM, Miro JM, Zamora L J Infect Dis. 2006 Sep 1;194(5):633-41

Glutamate released by dendritic cells as a novel modulator of T cell activation

Pacheco R; Oliva H; Martinez-Navio JM; Climent N; Ciruela F; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R

Journal of immunology (Baltimore, Md : 1950); 2006 Nov 15; 177(10); p. 6695-704

Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.

Sierra JM; Sanchez F; Castro P; Salvado M; de la Red G; Libois A; Almela M; March F; Espanol M; Sambeat MA; Romeu J; Brugal MT; Garcia de Olalla P; Gatell JM; Vila J; Garcia F; Lopez Colomes JL; Cayla JA; Coll P

Medicine; 2006 May; 85(3); p. 139-46

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

Gatell JM, Miro JM, Zamora L Lancet. 2006 Aug 5;368(9534):451-8

42

Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy.

Suy A; Martinez E; Coll O; Lonca M; Palacio M; de Lazzari E; Larrousse M; Milinkovic A; Hernandez S; Blanco JL; Mallolas J; Leon A; Vanrell JA; Gatell JM


Influence of Diabetes Mellitus on the Clinical Manifestations and Prognosis of Infective Endocarditis: A report from the International Collaboration on Endocarditis. Merged Database

Kourany, W., Miró J., Moreno A., Corey R., Pappas P., Abrutyn E., Hoen B., Habib G., Fowler V., Sexton D., Olaison L., Cabell C

Scand J Infect Dis. 2006; 38: 613-619

Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database

Kourany WM, Miro JM, Moreno A et al Scand J Infect Dis. 2006;38(8):613-9

Intrathoracic fat in HIV-infected patients.

Blanco JL; Biglia A; Martinez E; Sanchez M; de Lazzari E; Leon A; Milinkovic A; Larrousse M; Lonca M; Laguno M; Mallolas J; Gatell JM

HIV medicine; 2006 May; 7(4); p. 213-7

Liver Transplantation in HIV-Infected Patients: Update in 2006

Miró JM, Murillas J, Laguno M, Tuset M, Agüero F, Moreno A, Rimola A and the Hospital Clinic OLT in HIV Working Group

Hepatology Rev. 2006;3:16-29

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

Gatell JM, Miro JM, Zamora L Arch Intern Med. 2006 Aug 14-28;166(15):1632-41

Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?

Miro JM, Laguno M, Moreno A, Rimola A and the Hospital Clinic OLT in HIV Working Group

J Hepatol. 2006;44(1 Suppl):S140-5


C Cervera, C Agustí, MA Marcos, T Pumarola, F Cofán, M Navasa, F Perez-Villa, Antonio Torres, AMoreno

Diag Microbiol Infect Dis. 2006;55(1):47-54

Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study

Jimenez-Exposito MJ, Mestres CA, Claramonte X, Cartana R, Josa M, Pomar JL, Mulet J, Miro JM; en representacion del Grupo de Estudio de Endocarditis del Hospital Clinic-IDIBAPS

Rev Esp Cardiol. 2006 Mar;59(3):276-9

Periannular Complications in Infective Endocarditis Involving Native Aortic Valves

Anguera I., Miro JM., Evangelista A., Cabell C., San Roman JA., Vilacosta I., Almirante B., Ripoll T., Fariñas MC., Anguita M., Navas E., Gonzalez-Juanatey C., Garcia-Bolao I., Muñoz P., de Alarcón A., Sarriá C., Rufi G., Miralles F., Pare C., Fowler V., Mestres CA., de Lazzari E., Guma JR., Moreno A., Corey GR and the Aorto-Cavitary Fistula in Endocarditis Working Group

Am J Cardiol 2006; 98: 1254-1260

Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).

Sued O; Miro JM; Alquezar A; Claramonte X; Garcia F; Plana M; Arnedo M; de Lazzari E; Gil C; Manzardo C; Blanco JL; Martinez E; Mallolas J; Joseph J; Pumarola T; Gallart T; Gatell JM

Enfermedades infecciosas y microbiologia clinica; 2006 Apr; 24(4); p. 238-44

Progress towards an HIV vaccine based on recombinant bacillus Calmette-Guerin: failures and challenges.

Joseph J; Saubi N; Pezzat E; Gatell JM; Expert review of vaccines; 2006 Dec; 5(6); p. 827-38

43

Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies

Gatell JM, Miro JM, Zamora L J Infect Dis. 2006 Sep 1;194(5):612-22

Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe

Gatell JM, Miro JM, Zamora L J Acquir Immune Defic Syndr. 2006 Jun;42(2):229-37

Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe.

Bannister WP; Kirk O; Gatell JM; Knysz B; Viard JP; Mens H; Monforte AD; Phillips AN; Mocroft A; Lundgren JD

Journal of acquired immune deficiency syndromes (1999); 2006 Jun; 42(2); p. 229-37

Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia

Gatell JM, Miro JM, Zamora L AIDS 2006 May 12;20(8):1141-50

Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials

Lifson AR; Rhame FS; Belloso WH; Dragsted UB; El-Sadr WM; Gatell JM; Hoy JF; Krum EA; Nelson R; Pedersen C; Pett SL; Davey RT Jr;

HIV clinical trials; 2006 May-Jun; 7(3); p. 125-41

Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens

Alvarez-Martinez MJ; Miro JM; Valls ME; Moreno A; Rivas PV; Sole M; Benito N; Domingo P; Munoz C; Rivera E; Zar HJ; Wissmann G; Diehl AR; Prolla JC; de Anta MT; Gatell JM; Wilson PE; Meshnick SR and the Spanish PCP Working Group

Diagnostic microbiology and infectious disease; 2006 Oct; 56(2); p. 153-60

Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion.

Naranjo-Gomez M; Climent N; Cos J; Oliva H; Bofill M; Gatell JM; Gallart T; Pujol-Borrell R; Borras FE

Immunology; 2006 Dec; 119(4); p. 488-98

The cryopreserved mitral homograft in the tricuspid position for infective endocarditis

Carlos-A Mestres, Manuel Castellá, Asunción Moreno, J.Carlos Paré, Ana del Rio, Manuel Azqueta, Claudio Fernández, José Mª Miró, José Luis Pomar and the Hospital Clínic Endocarditis Study Group

J Heart Valve Dis.. 2006 May;15(3):389-91

The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era

Gatell JM, Miro JM, Zamora L Clin Trials. 2006;3(2):119-32

The International Collaboration on Endocarditis Merged Database Study Group. Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database

Lalani T, Kanafani ZA, Chu VH, Moore L, Corey GR, Pappas P, Woods CW, Cabell CH, Hoen B, Selton-Suty C, Doco-Lecompte T, Chirouze C, Raoult D, Miro JM et al.

Eur J Clin Microbiol Infect Dis. 2006 Jun;25(6):365-8

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study

Gatell JM, Miro JM, Zamora L HIV Med. 2006 May;7(4):218-30


Mallolas J; Arnedo M; Pumarola T; Erice A; Blanco JL; Martinez E; Gatell JM


44

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel

Hammer SM; Saag MS; Schechter M; Montaner JS; Schooley RT; Jacobsen DM; Thompson MA; Carpenter CC; Fischl MA; Gazzard BG; Gatell JM; Hirsch MS; Katzenstein DA; Richman DD; Vella S; Yeni PG; Volberding PA

Topics in HIV medicine : a publication of the International AIDS Society, USA; 2006 Aug-Sep; 14(3); p. 827-43

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

Hammer SM; Saag MS; Schechter M; Montaner JS; Schooley RT; Jacobsen DM; Thompson MA; Carpenter CC; Fischl MA; Gazzard BG; Gatell JM; Hirsch MS; Katzenstein DA; Richman DD; Vella S; Yeni PG; Volberding PA

JAMA : the journal of the American Medical Association; 2006 Aug 16; 296(7); p. 827

Revisió ¿Podemos mejorar el pronóstico de la endocarditis estafilocócica?

del Río A, Miró JM Enferm Infecc Microbiol Clin. 2006; 5(3):58-70

Complications of Native and Prosthetic Valve Infective Endocarditis: Update in 2006

Anguera I, Del Rio A, Moreno A, Pare C, Mestres CA, Miro JM

Curr Infect Dis Rep. 2006 Jun;8(4):280-8

Enfermedades Infecciosas y Microbiología Clínica: actividad editorial 2002-2005

Almirante B, Alonso J, Martinez-Martinez L, Miro JM, Pascual A

Enferm Infecc Microbiol Clin. 2006; 24(3):143-146

Infections due to HIV-2 and HTLV-1/2 in Spain

Toro C, Soriano V; Grupo Espanol de Estudio del VIH-2 y HTLV-1/2 (Miro JM, Sued O, Hosp. Clinic. Barcelona, Spain)

Enferm Infecc Microbiol Clin. 2006 Oct;24(8):481-2

Interacciones de los fármacos antirretrovirales: actualización

Tuset M, Miro JM, Carcelero E, Sarasa M, Codina C, Ribas J

Infecciones e Inmunología. 2006; 5 (2): 18-43

Management of end stage liver disease (ESLD): What is the current role of orthotopic liver tranbsplantation (OLT)?

JM Miró, M Laguno, A Moreno, A Rimola, the Hospital Clínic OLT in VIH Working Group

Journal of Hepatology. 2006; 44; S140-5

Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (Update January 2007)

Miro JM, Enferm Infecc Microbiol Clin. 2007 Jan;25(1):32-53

Carta Antiretroviral therapy in patients with primary HIV infection

Sued O, Iribarren JA, Arrizabalaga J, Miro JM Med Clin (Barc). 2006 Feb 4;126(4):157

Antiretroviral treatment in patient with advanced immunosuppression

Arribas JR, Pulido F, Gonzalez-Garcia JJ, Miro JM Med Clin (Barc). 2006 Feb 4;126(4):157-8

Considerations about the value of sonography for the measurement of regional body fat.

Martinez E; Milinkovic A; Bianchi L; Gatell JM AIDS (London, England); 2006 Feb 14; 20(3); p. 465-6

Noninvasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia

Garrabou G; Sanjurjo E; Miro O; Martinez E; Infante AB; Lopez S; Cardellach F; Gatell JM; Casademont J

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; 2006 Feb 15; 42(4); p. 584-5


Mallolas J; Gatell JM; Bruguera M AIDS (London, England); 2006 Aug 22; 20(13); p. 1785

Llibre Guía de bolsillo de interacciones farmacológicas en VIH

Tuset M, Miró JM, Codina C, Ribas J Sexta edición. Madrid. SiCom XXI SL. 2006 Depósito legal: M-38896-2006

Resumen Científico ICAAC-2006 Arribas JR, Miró JM, Rodríguez JL, De la Torre J (Eds)

Octaba Edición. Barcelona. Ediciones Permanyer. 2006. ISBN: 84-935225-4-6

Capítol llibre

45

Endocarditis infecciosa sobre válvula nativa.

Miró JM, Tornos P, Fernández-Guerrero ML En: Tratado SEIMC de Patología Infecciosa. Ausina V, Moreno S (Ed.). Segunda edición: Capítulo 132. Buenos Aires-Madrid: Editorial Médica Panamericana SA. 2006: 1293-1313

Farmacocinética e interacciones de tripanavir

Tuset M, Gratacòs L, Codina C, Miró JM Gatell JM, Mensa J y Zamora L (Eds). Tripinavir el Inhibidor de la proteasa de una generación. Capítulo 6. Barcelona. Editorial Antares, SCP . 2006: 107-143

Infección aguda por el VIH, tratamiento antirretroviral (TARV) inicial, paradas del TARV, terapias inmunomediadas y profilaxis postexposición accidental

Miró JM Arribas JR, Miró JM, Rodríguez JL, De la Torre Cisneros J (Eds).Resumen Científico ICAAC 2005. 7ª Edición. Barcelona. Ediciones P. Permanyer. 2006:55-62

Infección aguda por el VIH, tratamiento antirretroviral (TARV) inicial, paradas del TARV, terapias inmunomediadas y profilaxis postexposición accidental (PEP)

Miró JM Arribas JR, Miró JM, Rodríguez JL, De la Torre Cisneros J (Eds).Resumen Científico ICAAC 2006. 8ª Edición. Barcelona. Ediciones Permanyer. 2006:67-75

Infecciones producidas por el grupo Herpes (no VIH, no trasplante) y otros virus

Fortún J, Moreno A En: Resumen Científico ICAAC-2006. Barcelona, Ediciones Permanyer SL. 2006:107-13

Liver transplantation in HIV-infected patients

Miró JM, Agüero F, Murillas J, Laguno M, Tuset M, Moreno A, Rimola A

Mallolas J (Ed). HCV-HIV coinfection. Chapter 5. Barcelona. Editorial P. Permanyer. 2006: 109-126

Profilaxis y tratamiento de las infecciones oportunistas en los pacientes con Sid

Sued O, García F, Miró JM García JE, Gobernado M, Picazo JJ, Prieto J (Eds). Antimicrobianos en Medicina. 2ª Edición. Capítulo 50. Barcelona. Editorial Prous Science, SA. 2006: 641-654

Tratamiento de la infección por el virus de la inmunodeficiencia humana

Mallolas J, Miró JM, Gatell J García JE, Gobernado M, Picazo JJ, Prieto J (Eds). Antimicrobianos en Medicina. 2ª Edición. Capítulo 49. Barcelona. Editorial Prous Science, SA. 2006: 633-640

Truvada un fármaco esencial en el tratamiento inicial. Capítulo 3

Diego E, Fontanals S, Tuset M, Martín M, Miró JM Farmacocinética e interacciones farmacocinéticas de Truvada ®. Gatell JM, Mensa J y Zamora L (Eds). Barcelona. Editorial Antares, SCP. 2006: 33-68

Malalties Infeccioses - Projectes de recerca finançats 2006 Investigador

Principal Referència Ajut Entitat Nom Projecte Import Durada

Gatel JM ? Fundación Mútua Madrileña

Construcción de una vacuna contra el virus de la inmunodeficiencia humana tipo 1 basada en BCG y virus vaccinia

65.000 2005-2008

Gatell JM SAFR2005-05566 ? Estudio de la respuesta inmunitaria in vitro a una vacuna terapñeutica contra el VIH-1 reparada con células dendríticas mieloides autólogas pulsadas con diferentes inmunogenos

80.000,00 2005-2008

Gatell JM ? Concerted Action European Union. Program Biomed 2

Eurosida ? 2004-2006

Gatell JM safr2005-05566 ? Estudio de la respuesta inmunitaria in vitro a una vacuna terapéutica contra el VIH-1 reparada con células dendríticas micloides autólogas pulsadas con diferentes inmunógenos.

80.000 2005-2008

Gatell JM ? Fundación Mútua Construcción de unaq vacuna contra el virus de la 65.000 2005-2008

46

Madrileña inmunodeficiencia humana tipo I basada en BCG y virus vaccinia.

Gatell JM ? Proyecto Orvacs Vacunas terapéuticas contra el VIH ? 2004-2006 Gatell JM FIS 050130 Ministerio Sanidad y

Consumo Proyectos coordinados en epidemiología, investigación básica y clínica de la red de investigación en SIDA (Ris) para el año 2006.

53.550 2006

Miro JM PI 040363 FIS Fondo Investigacion Sanitaria

Estudio piloto del tratamiento inmunomediado de la infección aguda por el VIH con el fin de inducir una fuerte respuesta inmunoespecífica frente al VIH que permita el control de la replicación viral sin tratamiento retroviral (TARV)

148.925 2005-2007

Miro JM TOH/VIH-05 FIPSE Estudio FIPSE de trasplante hepático en pacientes infectados por el VIH en España. Estudio Gesida 45-05

571.359,8 2005-2008

Moreno MA ? Mútua Automovilística Madrileña

Investigación en el trasplante 60.000 2004-2006

Moreno MA FIS PI050315 Fondo Investigacion Sanitaria

Infección y trasplante. Consolidación de RESITRA en el marco RETICS. Explotación de la cohorte RESITRA

20.349 2006

Malalties Reumatològiques i del Sistema Immune

Malalties Reumatològiques i del Sistema Immune - Publicacions 2006 Títol Autors Cita Original Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Behcet's disease

Muñoz-Saa I, Cambra A, Pallares L, Espinosa G, Juan A, Pujalte F, Matamoros N, Mila J, Julia MR

Scand J Immunol 2006; 64: 77-82

Anti-inflammatory and immunosuppressive drugs and reproduction

Ostensen M; Khamashta M; Lockshin M; Parke A; Brucato A; Carp H; Doria A; Rai R; Meroni P; Cetin I; Derksen R; Branch W; Motta M; Gordon C; Ruiz-Irastorza G; Spinillo A; Friedman D; Cimaz R; Czeizel A; Piette JC; Cervera R; Levy RA; Clementi M; De Caroli

Arthritis research & therapy; 2006; 8(3); p. 209

Antiphospholipid antibodies associated with malignancies: Clinical and pathological characteristics of 120 patients

Gómez-Puerta JA, Cervera R, Espinosa G, Aguiló S, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J

Semin Arthritis Rheum 2006; 35: 322-32

Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases

Ramos-Casals M; Nardi N; Brito-Zeron P; Aguilo S; Gil V; Delgado G; Bove A; Font J

Seminars in arthritis and rheumatism; 2006 Apr; 35(5); p. 312-21

Autoantibodies and prediction of reproductive failure

Shoenfeld Y; Carp HJ; Molina V; Blank M; Cervera R; Balasch J; Tincani A; Faden D; Lojacono A; Doria A; Konova E; Meroni PL

American journal of reproductive immunology (New York, N.Y : 1989); 2006 Nov-Dec; 56(5-6); p. 337-44

Biochemical response to bisphosphonate therapy in pagetic patients with skull involvement

Peris P, Alvarez L, Vidal S, Kasper D, Leeming DJ, Monegal A, Angeles Martinez M, Pons F, Guanabens N

Calcif Tissue Int. 2006 Jul;79(1):22-6

Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment

Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van Maldergem L, Ralston S, Guanabens N, Migone N, Wientroub S, Divizia MT, Bergmann C, Bennett C, Simsek S, Melancon S, Cundy T, Van Hul W

J Med Genet. 2006 Jan;43(1):1-11

Catastrophic antiphospholipid syndrome presenting with renal thrombotic microangiopathy and diffuse proliferative glomerulonephritis

Gomez-Puerta JA; Salgado E; Cervera R; Aguilo S; Ramos-Casals M; Soler M; Torras A; Font J

Clinical and experimental rheumatology; 2006 Jan-Feb; 24(1); p. 110

47


Ramos-Casals M, Sanchez-Tapias JM, Pares A, Forns X, Brito-Zeron P, Nardi N, Vazquez P, Velez D, Arias I, Bove A, Plaza J, Rodes J, Font J

J Rheumatol 2006; 33: 1593-9

Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome: prevalence and clinical significance in 335 patients

Nardi N; Brito-Zeron P; Ramos-Casals M; Aguilo S; Cervera R; Ingelmo M; Font J

Clinical rheumatology; 2006 May; 25(3); p. 341-6

Epidemiology of systemic lupus erythematosus at the change of the millennium: lessons from the Euro-Lupus and the LUMINA projects

Cervera R; Khamashta MA Lupus; 2006; 15(1); p. 1-2

European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders

Wiik A; Cervera R; Haass M; Kallenberg C; Khamashta M; Meroni PL; Piette JC; Schmitt R; Shoenfeld Y

Lupus; 2006; 15(7); p. 391-6

Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications

Carmona F; Lazaro I; Reverter JC; Tassies D; Font J; Cervera R; Balasch J

American journal of obstetrics and gynecology; 2006 Feb; 194(2); p. 457-65

Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients

Bosch X; Guilabert A; Pallares L; Cerveral R; Ramos-Casals M; Bove A; Ingelmo M; Font J

Lupus; 2006; 15(9); p. 584-9

Inhaled steroids do not decrease bone mineral density but increase risk of fractures: data from the GIUMO Study Group

Sosa M, Saavedra P, Valero C, Guanabens N, Nogues X, del Pino-Montes J, Mosquera J, Alegre J, Gomez-Alonso C, Munoz-Torres M, Quesada M, Perez-Cano R,GIUMO Study Group

Journal of Clinical Densitometry 2006;9:154-8

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Miyakis S; Lockshin MD; Atsumi T; Branch DW; Brey RL; Cervera R; Derksen RH; DE Groot PG; Koike T; Meroni PL; Reber G; Shoenfeld Y; Tincani A; Vlachoyiannopoulos PG; Krilis SA

Journal of thrombosis and haemostasis : JTH; 2006 Feb; 4(2); p. 295-306

Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases

Ramos-Casals M, Robles A, Brito-Zeron P, Nardi N, Nicolas JM, Forns X, Plaza J, Yague J, Sanchez-Tapias JM, Font J

Semin Arthritis Rheum 2006; 36: 189-96.

Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients

Bucciarelli S; Espinosa G; Cervera R; Erkan D; Gomez-Puerta JA; Ramos-Casals M; Font J; Asherson RA

Arthritis and rheumatism; 2006 Aug; 54(8); p. 2568-76

nhaled steroids do not decrease bone mineral density but increase risk of fractures: data from the GIUMO Study Group

Jodar E, Torrijos A, Lozano-Tonkin C, Diaz-Curiel M, GIUMO Study Group

J Clin Densitom. 2006 Apr-Jun;9(2):154-8

Resultados del tratamiento con pilocarpina oral en 100 pacientes con síndrome de Sjögren primario

Brito-Zerón P, Ramos-Casals M, Nardi N, Font J

Med Clin (Barc) 2006; 126: 637

The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients

Bucciarelli S; Espinosa G; Asherson RA; Cervera R; Claver G; Gomez-Puerta JA; Ramos-Casals M; Ingelmo M

Annals of the rheumatic diseases; 2006 Jan; 65(1); p. 81-6

Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients

Ramos-Casals M; Nardi N; Lagrutta M; Brito-Zeron P; Bove A; Delgado G; Cervera R; Ingelmo M; Font J

Medicine; 2006 Mar; 85(2); p. 95-104

Revisió Anti-chromatin (anti-nucleosome) antibodies

Gomez-Puerta JA; Burlingame RW; Cervera R Lupus; 2006; 15(7); p. 408-11

48

Antineutrophil cytoplasmic antibodies

Bosch X; Guilabert A; Font J Lancet; 2006 Jul 29; 368(9533); p. 404

Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients

Gomez-Puerta JA; Cervera R; Espinosa G; Aguilo S; Bucciarelli S; Ramos-Casals M; Ingelmo M; Asherson RA; Font J

Seminars in arthritis and rheumatism; 2006 Apr; 35(5); p. 322-3295-104

Catastrophic antiphospholipid syndrome

Cervera R; Asherton RA Pathophysiology of haemostasis and thrombosis; 2006; 35(1-2); p. 181-6

Catastrophic antiphospholipid syndrome

Cervera R; Asherson RA; Font J Rheumatic diseases clinics of North America; 2006 Aug; 32(3); p. 575-90

European Working Party on Systemic Lupus Erythematosus: a 15-year report

Cervera R; Font J; Shoenfeld Y Autoimmunity reviews; 2006 Oct; 5(8); p. 549-53

Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease

Escarcega RO; Garcia-Carrasco M; Fuentes-Alexandro S; Jara LJ; Rojas-Rodriguez J; Escobar-Linares LE; Cervera R

Autoimmunity reviews; 2006 Nov; 6(1); p. 48-53

Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome

Espinosa G; Bucciarelli S; Cervera R; Gomez-Puerta JA; Font J

Autoimmunity reviews; 2006 Dec; 6(2); p. 68-71

Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry

Cervera R; Espinosa G; Bucciarelli S; Gomez-Puerta JA; Font J


Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors

Bucciarelli S; Cervera R; Espinosa G; Gomez-Puerta JA; Ramos-Casals M; Font J


Pathophysiology of Sjogren's syndrome

Garcia-Carrasco M; Fuentes-Alexandro S; Escarcega RO; Salgado G; Riebeling C; Cervera R

Archives of medical research; 2006 Nov; 37(8); p. 921-32

Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome

Gomez-Puerta JA; Cervera R; Espinosa G; Bucciarelli S; Font J


Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project"

Cervera R; Abarca-Costalago M; Abramovicz D; Allegri F; Annunziata P; Aydintug AO; Bacarelli MR; Bellisai F; Bernardino I; Biernat-Kaluza E; Blockmans D; Boki K; Bracci L; Campanella V; Camps MT; Carcassi C; Cattaneo R; Cauli A; Cervera R; Chwalinska-Sad

Autoimmunity reviews; 2006 Mar; 5(3); p. 180-6

The catastrophic antiphospholipid (Asherson's) syndrome and malignancies

Miesbach W; Asherson RA; Cervera R; Shoenfeld Y; Puerta JG; Bucciarelli S; Espinoza G; Font J

utoimmunity reviews; 2006 Dec; 6(2); p. 94-7

Treatment of bone disorders in liver disease

Pares A, Guanabens N J Hepatol. 2006 Sep;45(3):445-53

Cas Clínic Behcet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy

Gomez-Puerta JA; Espinosa G; Miro JM; Sued O; Llibre JM; Cervera R; Font J

IMAJ; 2006 Jul; 8(7); p. 513-4

Bilateral tibial stress fracture presenting as painful edemas in lower limbs

Peris P, Monegal A, Martinez M, Guanabens N Joint Bone Spine. 2006;73:557-9

Fixed ceramometallic prostheses over anterior and transzygomatic implants by using the sinus slot technique--report of a case

Penarrocha-Diago M; Boronat A; Cervera R; Garcia B

The Journal of oral implantology; 2006; 32(1); p. 38-40

49

Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome

Mundo J; Peris P; Monegal A; Navasa M; Cervera R; Guaniabens N

Lupus; 2006; 15(5); p. 304-7

Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome

Mundo J, Peris P, Monegal A, Navasa M, Cervera R, Guañabens N

Lupus 2006;15:304:7

Editorial Infectious origin of the antiphospholipid syndrome

Shoenfeld Y; Blank M; Cervera R; Font J; Raschi E; Meroni PL

Annals of the rheumatic diseases; 2006 Jan; 65(1); p. 2-6

Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis?

Asherson RA; Cervera R; Shepshelovich D; Shoenfeld Y

The Journal of rheumatology; 2006 Jun; 33(6); p. 1038-44

Primary pulmonary arterial hypertension and the systemic autoimmune diseases

Cervera R; Asherson RA IMAJ; 2006 Apr; 8(4); p. 277-9

Carta Antiphospholipid antibody-associated thrombocytopenia and the paradoxical risk of thrombosis

Fortea J; Obach V; Cervera R; Gamarra AI Lupus; 2006; 15(1); p. 58

Antiphospholipid syndrome and minimal change nephropathy

Rossinol T; Cervera R; Lopez C; Sole M; Ramos-Casals M; Font J

Lupus; 2006; 15(8); p. 547-8

V meeting of the European forum on antiphospholipid antibodies

Cervera R; Font J; Tincani A; Boffa MC Autoimmunity reviews; 2006 Aug; 5(7); p. 499-507

Capítol Llibre Marcadores bioquímicos del recambio óseo en la evaluación de la enfermedad

Peris P, Alvarez L, Guañabens N En “Enfermedad Ósea de Paget. SCM eds, 2006; pp:71-80

Medicina d'Atenció Primària

Malalties d'Atenció Primària - Publicacions 2006 Títol Autors Cita Original Análisis de los estudios publicados sobre el incumplimiento terapéutico en la hipertensión arterial en España entre los años 1984 y 2005

Márquez E, Vil V, Casado JJ, Martell N, de la Figuera M, et al.

Aten Primaria 2006; 38:325-32

Malalties Reumatològiques i del Sistema Immune - Projectes de recerca finançats 2006

Inv. Principal Ref. Ajut Entitat Nom Projecte Import € Durada Cervera R PI 03/028

Ministerio

y Consumo Alteraciones genéticas en el funcionalismo plaquetario, la fibrinolisis y

ma inmunitario innato como factores predisponentes de arteriosclerosis en pacientes con lupus eritematoso sistémico

116.265

2003-2006

Guañabens N PI050044 FIS Estudio del efecto bifásico de la hormona paratiroidea (PTH) sobre stos humanos primarios en cultivo. Acción sobre el sistema OPG/RANKL rcadores de diferenciación osteoblástica RUNX2/CBFA1, osteocalcina y

geno tipo I

?? 2006-2008

50

Automedida de la presión arterial domiciliaria. Influencia del sistema de cáculo de la media en el diagnóstico de la Hipertensión de bata blanca



Bacterial etiology of chronic bronchitis exacerbations treated by primary care physicians

Llor C; Cots JM; Herreras A Archivos de bronconeumologia; 2006 Aug; 42(8); p. 388-93

Consumo de fruta y verduras en la prevención del ictus. ¿Incide el consumo de frutas y verduras en el riesgo de presentar un ictus?

Coca A. Jano 2006; 1629:39-40

Effect of intervention promoting a reduction in antibiotic prescribing by improvement of a diagnostic procedures: a prospective, before and after study in general practice

Bjerrum L, Cots JM, Llor C, Molist N, Munck A Euro J Clin Pharmacol 2006; 62: 913-8

Effect of intervention promoting a reduction in antibiotic prescribing by improvement of diagnostic procedures: a prospective, before and after study in general practice.

Bjerrum L; Cots JM; Llor C; Molist N; Munck A European journal of clinical pharmacology; 2006 Nov; 62(11); p. 913-8

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial

Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Gired X, Jamerson K, Larochelle P, MacDonald ThM, Schmieder RE, Schork MA, Stolf P, Viskoper R, Widimsky J, Zanchetti A, for the VALUE Trial Investigators

Journal of Hypertension 2006; 24: 1405-1412

Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study

Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martinez JJ, Martin-de Pablos JL, et al.

J Hypertens. 2006 Jan;24(1):169-75

Estimated risk of a first stroke and conditioning factors in Spanish hypertensive women. The RIMH study.

Coca A; Redon J; Cea-Calvo L; Lozano JV; Navarro J; Fernandez-Perez C; Bonet A; Gonzalez-Esteban J

Blood pressure; 2006; 15(4); p. 237-44

Estrategias para un control eficaz dela hipertensión arterial en España. Documento de consenso

Coca A; Aranda P; Bertomeu V; Bonet A; Esmatjes E; Guillen F; Hernandez-Moreno J; Llisterri JL; Marin-Iranzo R; Megia C; Rodriguez-Manas L; Suarez C;

Revista Clinica espanola; 2006 Nov; 206(10); p. 510-4

Etiología bacteriana de la agudización de la bronquitis crónica en atención primaria

Llor C, Cots JM , Herreras A Arch Bronconeumol. 2006; 42:388-9

Factores de riesgo de elevado coste de las agudizaciones de la bronquitis crónica y la EPOC

Llor C, Naberan K, Cots JM, Molina J, Ros F, Miravitlles M

Arch Bronconeumol 2006;42:175-82




Indicadores de calidad en unidades asistenciales de hipertensión arterial en España: indicadores de estructura en el estudio QUALITHA

Poch E, Felip A, Davins J, Coca A Revista Clínica Española 2006; 206: 541-8

Predictors of adverse outcome among patients with hypertension and coronary artery disease

Pepine CJ, Kowey PR, Kupfer S, Kollock RE, Benetos A, Mancia G, Coca A, Cooper-DeHoff RM, Handberg E, Gaxiola E, Sleight P, Conti CR, Hewkin AC, Tavazzi L, for the INVEST Investigators

Journal of the American College of Cardiology 2006; 7: 547-51

51

Reducción de la prescripción de antibióticos en la sinusitis mediante la realización de una auditoria

Llor C, CotsJM, Molist N, Boada A Aten Primaria 2006; 38:304-5

Rendiment diagnòstic de l’automesura se la pressió arterial domiciliària en la Hipertensió Clínica Aïllada

J. Bayó, C. Roca, A. Dalfó, MM Martín-Baranera, C. Medrano

Butlletí de la Societat Catalana de Medicina Familiar i Comunitària 2006; 24:14-20

Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease]

Llor C; Naberan K; Cots JM; Molina J; Ros F; Miravitlles M

Archivos de bronconeumologia; 2006 Apr; 42(4); p. 175-82

Tratamiento y control del riesgo cardiovascular en atención primaria en España. Estudio PREVENCAT.

Coca A; Dalfo A; Esmatjes E; Llisterri JL; Ordonez J; Gomis R; Gonzalez-Juanatey JR; Martin-Zurro A


Variabilidad de la prescripción antibiótica en las infecciones respiratorias en dos países de Europa

Llor C, Cots JM, Boada A, Bjerrum L, Gahrn-Hansen B, Munck A, et al

Enferm Infecc Microbiol Clin 2005; 23:598-604

Revisió Concerning World Heart Day Morales A, Coca A Revista Española de Cardiología 2006;

59:184 Efermedades importadas en inmigrantes: mito y realidad

C. Roca, X. Balanzó An Sist Sanit Nav 2006; 29 (supl 1):139-144

Enfoque conjunto de los factores de riesgo cardiovascular

De la Figuera M, Llisterri JL Med Clin (Barc) 2006; 127:774-5

Ensayos clínicos de morbimortalidad con calcioantagonistas en hipertensión.

De la Figuera M

Hipertensión 2006; 23 (extraord. 2); 20-7

Estrategias para un control eficaz de la hipertensión arterial en España. Documento de Consenso

Coca A, Aranda P, Bertomeu V; Bonet A, Esmatjes E, Guillén F, Hernández-Moreno J, Llisterri JL, Marín-Iranzo R, Megía C, Rodríguez-Mañas L, Suarez C

SEMERGEN 2006; 32: 30-3

Estudio ASCOT: prevención de eventos vasculares con diferentes combinaciones de fármacos antihipertensivos: la reducción de la presión arterial es lo que importa (en parte)

De la Figuera M Atención Primaria Basada en la Evidencia 2006; 1: 184

Importancia del control de la presión arterial en al reducción de la morbimortalidad cardiovascular

Coll de Tuero G, De la Figuera M Drugs Expert 2006. Adis. Madrid

Inhibidores de la renina De la Figuera M, Vinyoles E Hipertensión 2006; 23: 216-21 Leptina, obesidad e hipertensión arterial

Vidal J, Coca A Medicina Clinica (Barc) 2006; 126: 695-696

Carta Qualitative indicators in antibiotic prescription: Are they the most appropriate ones?

Llor C; Cots JM; Molist N; Boada A; Bayona C; Bjerrum L

Atencion primaria / Sociedad Espanola de Medicina de Familia y Comunitaria; 2006 Sep 30; 38(5); 307-8; author reply 308-9

Llibre Avances en hipertensión. Presión arterial sistólica, presión de pulso y riesgo cardiovascular

Coca A y Sierra C Editorial Juste. Barcelona, 2006. (Depósito Legal: B-1487-2006)

52

Enfermedad cardiovascular en el paciente con hipertensión arterial. El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial

Gil A, Coca A (Ed.) Jarpyo Editores. Madrid, 2006. (Depósito Legal: M-42443-2006)

Eventos Cerebrovasculares e Hipertensión Arterial. ¿Qué hemos aprendido del estudio MOSES?

Coca A Editorial Grupo Ars XXI de Comunicación. Barcelona, 2006. (ISBN 84-9751-190-5 Depósito Legal: M-7940-2006)

Hipertensión arterial en Atención Primaria. Evidencia y práctica clínica.

De la Figuera M, Diogène E, Brotons C (eds) 2ª Edición, Barcelona, Euromedice, 2006. ISBN: 84-934482-9-X (obra completa). 84-96727-00-9 (Volumen I)

Manual de monitorización ambulatoria de la presión arterial y técnicas afines

Coca A, Mion D, Pickering T, Ramos F Editorial Médica A.W.W.E. S.L. Madrid, 2006. (ISBN 950-762-318-3. Depósito legal: M-50229-2006)

Capítol llibre Causas de mal cumplimiento del tratamiento

De la Figuera M En Suárez C (coord). Prevención de la progresión de la enfermedad cardiovascular. Importancia del cumplimiento terapéutico. Farmacia Comunicación SL. Madrid 2006; 27-39

Clasificación y fisiopatología del ictus, consecuencias y secuelas

Armario P, de la Figuera M En El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores SA. Madrid 2006: 271-77

Epidemiologia y factores de riesgo para el ictus.

Armario P, de la Figuera M En El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores SA. Madrid 2006: 261-70

La hipertensión arterial en el síndrome metabólico

Coca A, Sierra C HTA y síndrome metabólico. Acción Médica grupo. Madrid, 2006. (Depósito legal: M-52.180-2006)

Patologia infecciosa del tracte respiratori baix

Bonet Monne S., Casals Font A., Cots Yago JM., Falco Ferrer V.,Gonzalez Saavedra MI., Hospital Guardiola I., Luque Alonso A.,Pahissa Berga A., Pericas Bosch J., Serrano de Marco MT.,Simonet Aineto PJ., Van Esso Arbolave D

Guies de practica clinica i material docent, num. 11. Barcelona: Institut Catala de la Salut, 2006

Presión arterial. Tratamiento antihipertensivo y riesgo cardiovascular. Enfermedad cardiovascular en el paciente con hipertensión arterial.

Sierra C, Coca A El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores. Madrid, 2006. (Depósito Legal: M-42443-2006)

Prevención del ictus con el tratamiento antihipertensivo.

Coca A, de la Figuera M En El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores SA. Madrid 2006: 323-35

Prevención del ictus con el tratamiento antihipertensivo. Enfermedad cardiovascular en el paciente con hipertensión arterial

Coca A, de la Figuera M El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores. Madrid, 2006. (Depósito Legal: M-42443-2006)

Prevención primaria del ictus con el tratamiento antihipertensivo. Conclusiones y recomendaciones

Coca A, Sierra C El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores. Madrid, 2006. (Depósito Legal: M-42443-2006)

Respiratorio y atención primaria Torres A, Naberán K Depósito legal : B-950-06 JC Ediciones Médicas, S.L.. Barcelona (España), Vol 1:1, 2006

53

Oncologia Clínica

Oncologia Clínica - Publicacions 2006 Titol Autors Cita Originals Activation of nuclear factor-kappa B is linked to resistance to eoadjuvant chemotherapy in breast cancer patients

Montagut C, Tusquets I, Ferrer B, Corominas JM, Bellosillo B, Campas C, Suarez M, Fabregat X, Campo E, Gascón P, Serrano S, Fernández PL, Rovira A, Albanell J

Endocr Relat Cancer 13: 607-616, 2006

Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-[alpha] in patients with metastatic melanoma

González-Cao M, Malvehy, J, Marti, R, Conill C, Sanchez M, Martin M, Carrera C, Herrero J, Gascon P, Mellado B, Castel T, Puig S

Melanoma Research 16(1):59-64, 2006

Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells

Codony J, Tapia M, Bosch M, Oliva C, Domingo-Domènech J, Mellado B, Rolfe M, Ross J, Gascón P, Rovira A, Albanell J

Mol Cancer Ther 5: 665-675, 2006

Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY

Birgegard G, Gascón P, Ludwig H. Eur J Haematol 77(5):378-86, 2006

Independent Risk Factors For Anemia In Cancer Patients Receiving Chemotherapy: Results From The European Cancer Anaemia Survey (ECAS)

Barrett-Lee P, Ludwig H, Birgegård G, Bokemeyer C, Gascon P, et al

Oncology 70: 34-48, 2006

Inhibitors of angiogenesis Almendro V, Gascón P Clin Transl Oncol 8: 475-481, 2006 Interleukin 6, a Nuclear Factor-KBTarget, Predicts resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-KB Inhibition by PS-1145 Enhances Docetaxel AntitumorActivity.

J Domingo-Domenech,C Oliva, A Rovira, J Codony-Servat, M Bosch, X Filella, C Montagut, M Tapia, C Campa, L Dang, M Rolfe, JS Ross, P Gascon, J Albanell, and B Mellado

Clin Cancer Res 12: 5578-5586, 2006

Molecular biology of renal cell carcinoma

Mellado B, Gascón P Clin Transl Oncol 10: 706-710, 2006

Molecular biology of renal cell carcinoma.

Mellado B; Gascon P Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico; 2006 Oct; 8(10); p. 706-10

Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer

Maurel J, Martin-Richard M, Conill C, Sanchez M, Petriz L, Gines A, Miquel R, Gallego R, Cajal R, Ayuso C, Navarro S, Marmol M, Nadal C, Auge JM, Fernández-Cruz L, Gascón P

Int J Radiat Oncol Biol Phys 66: *1391-1398, 2006

Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy

Grau JJ, Palmero R, Marmol M, Domingo-Domènech J, Monzó M, Fuster J, Vidal O, Fondevila C, Garcia-Valdecasas JC

World J Surg Oncol 4: 53-61, 2006

Carta

54

Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY

Birgegard G; Gascon P; Ludwig H European journal of haematology; 2006 Nov; 77(5); p. 378-86

Oncologia Clínica - Projectes de recerca finançats 2006 Investigador Principal Referència Ajut Entitat Nom Projecte Import Durada

Gascon P FISS PI041353 Ministerio de Sanidad y Consumo

Efecto del microambiente medular en la integración de las células de cáncer de mama en la metástasis ósea: Papel del gen PPT-I y del factor TGF-b

59.800 2005-2008

Semiologia General

Semiologia General - Publicacions 2006 Títol Autors Cita Original Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis

Cid MC; Hoffman MP; Hernandez-Rodriguez J; Segarra M; Elkin M; Sanchez M; Vilardell C; Garcia-Martinez A; Pla-Campo M; Grau JM; Kleinman HK

Rheumatology (Oxford, England); 2006 Nov; 45(11); p. 1356

Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases

Ramos-Casals M; Nardi N; Brito-Zeron P; Aguilo S; Gil V; Delgado G; Bove A; Font J

Seminars in arthritis and rheumatism; 2006 Apr; 35(5); p. 312-21


Ramos-Casals M; Sanchez-Tapias JM; Pares A; Forns X; Brito-Zeron P; Nardi N; Vazquez P; Velez D; Arias I; Bove A; Plaza J; Rodes J; Font J

The Journal of rheumatology; 2006 Aug; 33(8); p. 1593-9

Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption.

Zamora-Ros R; Urpi-Sarda M; Lamuela-Raventos RM; Estruch R; Vazquez-Agell M; Serrano-Martinez M; Jaeger W; Andres-Lacueva C

Clinical chemistry; 2006 Jul; 52(7); p. 1373

Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial.

Estruch R; Martinez-Gonzalez MA; Corella D; Salas-Salvado J; Ruiz-Gutierrez V; Covas MI; Fiol M; Gomez-Gracia E; Lopez-Sabater MC; Vinyoles E; Aros F; Conde M; Lahoz C; Lapetra J; Saez G; Ros E

Annals of internal medicine; 2006 Jul 4; 145(1); p. 1

Evidence of apoptosis in alcoholic cardiomyopathy.

Fernandez-Sola J; Fatjo F; Sacanella E; Estruch R; Bosch X; Urbano-Marquez A; Nicolas JM

Human pathology; 2006 Aug; 37(8); p. 1100-10

Increased levels of atherosclerosis markers in salt-sensitive hypertension.

Larrousse M; Bragulat E; Segarra M; Sierra C; Coca A; de La Sierra A;

American journal of hypertension : journal of the American Society of Hypertension; 2006 Jan; 19(1); p. 87-93

Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients

Bosch X; Guilabert A; Pallares L; Cerveral R; Ramos-Casals M; Bove A; Ingelmo M; Font J

Lupus; 2006; 15(9); p. 584-9

Longitudinal study on mitochondrial effects of didanosine-tenofovir combination

Lopez S; Negredo E; Garrabou G; Puig J; Ruiz L; Sanjurjo E; Ramos X; Infante AB; Casademont J; Cardellach F; Clotet B; Miro O

AIDS research and human retroviruses; 2006 Jan; 22(1); p. 33-9

Main training in medical specialties: a challenge of the present for a better health system

Teres J; Capdevila JA; Nonell F; Cardellach F; Bundo M; Torres M

Medicina clinica; 2006 Jun 24; 127(4); p. 139-44

55

Predictors of adverse outcome among patients with hypertension and coronary artery disease

Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;

Journal of the American College of Cardiology; 2006 Feb 7; 47(3); p. 547-51

Relation of left ventricular hypertrophy to regional cerebral blood flow: single photon emission computed tomography abnormalities in essential hypertension

Sierra C, de la Sierra A, Lomeña F, Paré JC, Larrousse M, Coca A

The Journal of Clinical Hypertension 2006; 8(10):700-705

Scientific evidence of interventions using the Mediterranean diet: a systematic review.

Serra-Majem L; Roman B; Estruch R Nutrition reviews; 2006 Feb; 64(2 Pt 2); p. S27-47

Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir.

Miro O; Garrabou G; Lopez S; Deig E; Vidal I; Infante AB; Cardellach F; Casademont J; Pedrol E

Antiviral therapy; 2006; 11(5); p. 625-30

Total polyphenol intake estimated by a modified Folin-Ciocalteu assay of urine

Roura E; Andres-Lacueva C; Estruch R; Lamuela-Raventos RM

Clinical chemistry; 2006 Apr; 52(4); p. 749

Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients

Ramos-Casals M; Nardi N; Lagrutta M; Brito-Zeron P; Bove A; Delgado G; Cervera R; Ingelmo M; Font J

Medicine; 2006 Mar; 85(2); p. 95-104

Revisió ¿Cuál es la presión idónea en el hipertenso de alto riesgo?

Coca A, Sierra C Jano 2006; 1597: 47-50

White matter lesions and cognitive impairment as silent cerebral disease in hypertension

Sierra C, Coca A Scientific World Journal 2006; 6: 494-501

Cas Clínic Sustained spontaneous clinical remission in giant cell arteritis: report of two cases with long-term followup

Hernandez-Rodriguez J; Garcia-Martinez A; Espigol-Frigole G; Grau JM; Collado A; Cid MC

Arthritis and rheumatism; 2006 Feb 15; 55(1); p. 160-2

Editorial Towards the best physician for the community

Cardellach F; Vilardell M Medicina clinica; 2006 Jun 24; 127(4); p. 136-8

Carta Noninvasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia

Garrabou G; Sanjurjo E; Miro O; Martinez E; Infante AB; Lopez S; Cardellach F; Gatell JM; Casademont J

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; 2006 Feb 15; 42(4); p. 584-5

Stimulatory autoantibodies to the PDGF receptor in scleroderma

Lozano E; Segarra M; Cid MC The New England journal of medicine; 2006 Sep 21; 355(12); p. 1278

Semiologia General - Projectes de recerca finançats -2006 Investigador

Principal Referència

Ajut Entitat Nom Projecte Import Durada

Cardellach F PI041239 Fondo de Investigación Sanitaria

Intoxicación por monóxido de carbono: tratamiento con oxigeno normobarico o hiperbarico y su correlación con la actividad del complejo IV mitocondrial y el grado de peroxidación lipidica de linfocitos de sangre periferica

94.990 2005-2007

56

Casademont J Red-G003/11 022681 Ordre: 015

MSCO – Ministerio de Sanidad y Consumo

Estudio clínico-epidemiológico y molecular de las enfermedades de la cadena respiratoria mitocondrial en España

20.147,65 2004-2006

Cid MC SAF2005-06250

Ministerio de Educación y Ciencia

Factores relacionados con el mantenimiento de la inflamación y la oclusión vascular. Implicaciones en la evolución clínica de los pacientes con arteritis de células gigantes

140.420 2005-2008

Cid MC SAF2005-06250

Ministerio de Educación y Ciencia

Factores relacionados con el mantenimiento de la inflamación y la oclusión vascular. Implicaciones en la evolución clínica de los pacientese con arteritis de células gigantes

140.420 2005-2008

Estruch R PI051519

FIS Efectos de la dieta mediterrànea en la prevención de la enfermedad cardiovascular

70.329 2006

Estruch R AGL2006-14228-C03-01/ALI

MEC Balance beneficio/riesgo del contenido de polifenoles y alcohol del vino

32.000 2006-2008

Estruch R AGL2004-08378-C02-02

MEC Biodisponibilidad de los fenoles del cacao: Bases científicas de la interacción de los fenoles y los marcadores inflamatorios de la arteriosclerosis

115.000 2005-2007

Estruch R PI041837 FIS Mecanismos básicos de los efectos de la dieta mediterránea sobre la enfermedad cardiovascular

84.525 2004-2006

Fernandez Sola J Fundación Privada MAPFRE-Medicina

Evaluación de parámetros de calidad de vida y recuperación funcional de pacientes con fatiga crónica en los diveros estadíos de la enfermedad.

9.000 Febrero 2005-Marzo 2006

Grau JM 2005SGR00300 Agencia de Gestió d´Ajuts Universitaris i de Recerca

Grup de Recerca Múscular 35.600 2005-2007

Grau JM PI04464 Fondo de Investigación Sanitario

Angiogénesis y citocinas como factores pronósticos en la dermatomiositis. Caracterización del síndrome antisintetasa

31.050 2005-2007

Grau JM FIS PI040464 FIS Angiogénesis y citocinas como factores pronósticos en la dermatomiositis. Caracterización del síndrome antisintetasa

31.050 2004-2006

Nicolas JM PI050164 FIS Marcadores biológicos del fracaso multiorgánico en el shock séptico 60.000 2005-2008

Hospitals Col·laboradors

Publicacions Hospitals Col·laboradors Títol Autors Cita Original Automedida de la presión arterial domiciliaria. Influencia del sistema de cáculo de la media en el diagnóstico de la Hipertensión de bata blanca



Cardiovascular risk factors in patients aged 85 or older with ischemic stroke

Arboix A; Miguel M; Ciscar E; Garcia-Eroles L; Massons J; Balcells M

Clinical neurology and neurosurgery; 2006 Oct; 108(7); p. 638-43

Clinical implications of headache in lacunar stroke: relevance of site of infarct

Arboix A; Grau-Olivares M; Garcia-Eroles L; Massons J; Comes E; Targa C

Headache; 2006 Jul-Aug; 46(7); p. 1172-80

Clinical study of 39 patients with atypical lacunar syndrome

Arboix A; Lopez-Grau M; Casasnovas C; Garcia-Eroles L; Massons J; Balcells M

Journal of neurology, neurosurgery, and psychiatry; 2006 Mar; 77(3); p. 381-4

Clustering of cardiovascular risk factors and prevalence of metabolic syndrome in subjects with resistant hypertension

Hernandez del Rey R; Armario P; Martin-Baranera M; Castellanos P

Medicina clinica; 2006 Jul 15; 127(7); p. 241-5

Determinants of early outcome in spontaneous lobar cerebral hemorrhage

Arboix, Manzano C, García-Eroles L, Massons J, Oliveres M, Parra O, Targa C

Acta Neurol Scand 2006; 114:187-92

57

Differences in the etiology of community-acquired penumonia according to site of care: A population-based study

Almirall J. Et al. GEMPAC Study Group (... O. Parra...)

Respiratory Medicine 2007; 101:2168-75




Impact of female gender on prognosis in type 2 diabetic patients with ischemic stroke

Arboix A; Milian M; Oliveres M; Garcia-Eroles L; Massons J

European neurology; 2006; 56(1); p. 6

NARP-MILS syndrome caused by 8993 T > G mitochondrial DNA mutation: a clinical, genetic and neuropathological study

Rojo A; Campos Y; Sanchez JM; Bonaventura I; Aguilar M; Garcia A; Gonzalez L; Rey MJ; Arenas J; Olive M; Ferrer I

Acta neuropathologica; 2006 Jun; 111(6); p. 610-6

Prevalence of hypertension in elderly long-term care residents in Spain. The Geriatric HTA study

Martin-Baranera M; Sanchez Ferrin P; Armario P Medicina clinica; 2006 Nov 11; 127(18); p. 681-7

Prognostic value of headache in cardioembolic stroke

Arboix A Medicina clinica; 2006 Jun 3; 127(1); p. 5-7

Quilotorax y ascitis quilosa. Manifestación inicial de un Síndrome Nefrótico

Bonnin. M, Pelegrí A, Parra O Med Clin 2006; 127:718

Rendiment diagnòstic de l’automesura se la pressió arterial domiciliària en la Hipertensió Clínica Aïllada

J. Bayó, C. Roca, A. Dalfó, MM Martín-Baranera, C. Medrano

Butlletí de la Societat Catalana de Medicina Familiar i Comunitària 2006; 24:14-20

Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease

Almagro P; Barreiro B; Ochoa de Echaguen A; Quintana S; Rodriguez Carballeira M; Heredia JL; Garau J

Respiration; international review of thoracic diseases; 2006; 73(3); p. 311

Revisió Efermedades importadas en inmigrantes: mito y realidad

C. Roca, X. Balanzó An Sist Sanit Nav 2006; 29 (supl 1):139-44

Hepatitis B en situaciones especiales

Torres M Gastroenterologia y Hepatologia 2006; 29(supl 2):16-81

Nocturnal hypoxia is associated with silent cerebrovascular disease: An original approach

Parra O Am J Hypertens. 2006 Aug;19(8):876-7

Cas Clínic Tuberculosis, ancylostomiasis and eosinophilic pleural effusion

Rodriguez E; Delgado Y; Buges J; Bastida T; Torres M

Anales de medicina interna (Madrid, Spain : 1984); 2006 Jan; 23(1); p. 46-7

Lllibre Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición)

Arboix A Ed. Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X M-10959-2006

Capítol llibre Colitis colágena y linfocítica Fernández-Bañares F, Viver JM En: Tratamiento de las enfermedades

gastroenterológicas. Ponce J ed. Ediciones Doyma S.L. Barcelona, 2006; Capítulo 32, p. 295-300

Ecocardiografía Alió J, Ruiz-Majoral A, Arboix A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X

58

Electrocardiograma Arboix A, Martorell E, Alió J En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X

Examen físico general Arboix A, Martí-Vilalta JL En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X

Historia Clínica Martí-Vilalta Jl, Martí-Fàbregas J, Arboix A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X

Ictus: tipos etiológicos y criterios diagnóstico

Arboix A, Díaz J, Pérez-Sempere A, Alvarez-Sabín J En: Guía para el diagnóstico y tratamiento del ictus. Guías oficiales de la Sociedad Española de Neurología. Ed. Prous Science SA, Barcelona. 2006.ISBN: 84-8124-225-X

Métodos diagnósticos en el infarto cerebra

Arboix A, Dávalos A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X

Métodos diagnósticos en el infarto migrañoso

Massons J, Arboix A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X

Polisomnografía Parra O En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X

Presentación Arboix A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición) Arboix A (ed). Ed. Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X

Profilaxis primaria y secundaria de la hepatitis B

Torres M En: Planas Vilà R, Solà Lamoglia R, eds. Hepatitis B. Manual para Atención Primaria. Barcelona: Mayo Ediciones, 2006. ISBN84-96537-30-7

Trastornos de la respiración durante el sueño y accidente vascular cerebral

Parra O, Arboix A En: Santamaria J ed. Continua Neurológica. Trastornos del sueño. Barcelona. Grupo ARS XXI de Comunicación 2006. ISBN 849751237.

Hospitals col·laboradors - Projectes de recerca finançats 2006 Investigador

Principal Referència

Ajut Entitat Nom Projecte Import Durada

Torres M PI03/1131 Instituto de Investigación Carlos III

Accidentes biológicos parenterales en el personal sanitario. Análisis de los factores prevenibles mediante precauciones estándar

3.450 2004-2006

59

Economia

60

61

Despeses Funcionament Ordinari 2006

Beca col·laboració 4.851,00 Biblioteca/Documentació 495,45 Correu/Missatgeria 554,83 Equipament Inventariable Secretaria 1.859,45 Fotografia 85,72 Funcionament 171,21 Habilitats Clíniques 25.340,00 Material Docent Inventariable 8.332,43 Material oficina/fotocòpies 5.740,99 Microscopia Electrònica 157,85 Reparacions 121,86 Software 433,49 Telèfon 449,29 Xarxa 400,80 Total assignació 2006 48.994,37

+

Despeses Funcionament Ordinari 2006 Habilitats Clíniques

Material Docent Inventariable

Material oficina/fotocòpies

Beca col·laboració

Equipament InventariableSecretariaCorreu/Missatgeria

Biblioteca/Documentació

Telèfon

Software

Xarxa

Documents

Departament Medicina Memòria 2006